EurekaMag PDF full texts Chapter 46,972

Carr, B.I.; Zajko, A.; Bron, K.; Orons, P.; Sammon, J.; Baron, R. 1997: Phase Ii study of Spherex (degradable starch microspheres) injected into the hepatic artery in conjunction with doxorubicin and cisplatin in the treatment of advanced-stage hepatocellular carcinoma: interim analysis. Seminars in Oncology 24(2 Suppl 6: S6

Itoh, K.; Tsukamoto, E.; Kakizaki, H.; Nonomura, K.; Koyanagi, T.; Furudate, M.; Torizuka, K. 1993: Phase Ii study of Tc-99m MAG3 in patients with nephrourologic diseases. Clinical Nuclear Medicine 18(5): 387-393

Twelves, C.; Campone, M.; Coudert, B.; Van den Bent, M.; de Jonge, M.; Dittrich, C.; Rampling, R.; Sorio, R.; Lacombe, D.; de Balincourt, C.; Fumoleau, P. 2002: Phase Ii study of XR5000 (DACA) administered as a 120-h infusion in patients with recurrent glioblastoma multiforme. Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(5): 777-780

Meropol, N.J.; Pazdur, R.; Vincent, M.; Willson, J.K.; Kelsen, D.P.; Douglass, H.O. 1996: Phase Ii study of ZD1694 in patients with advanced gastric cancer. American Journal of Clinical Oncology 19(6): 628-630

Planting, A.S.; de Wit, R.; van der Burg, M.E.; Stoter, G.; Verweij, J. 1996: Phase Ii study of a closely spaced ifosfamide--cisplatin schedule with the addition of G-CSF in advanced non-small-cell lung cancer and malignant melanoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 7(10): 1080-1082

Wagenaar, H.C.; Pecorelli, S.; Vergote, I.; Curran, D.; Wagener, D.J.; Kobierska, A.; Bolis, G.; Bokkel-Huinink, W.T.; Lacave, A.J.; Madronal, C.; Forn, M.; de Oliveira, C.F.; Mangioni, C.; Nooij, M.A.; Goupil, A.; Kerbrat, P.; Marth, C.H.; Tumolo, S.; Herben, M.G.; Zanaboni, F.; Vermorken, J.B. 2001: Phase Ii study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer. European Journal of Gynaecological Oncology 22(3): 187-193

Sugita, T.; Matsunaga, K.; Kobayashi, H.; Horikawa, S.; Suzuki, Y.; Nishiyama, H.; Maekawa, N.; Matsumoto, H.; Okazaki, M.; Katagami, N. 1994: Phase Ii study of a continuous five-day intravenous infusion of cisplatin and etoposide with concurrent chest radiation therapy in limited stage small cell lung cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(14): 2479-2483

Feliu, J.; Mel, R.; Borrega, P.; López Gómez, L.; Escudero, P.; Dorta, J.; Castro, J.; Vázquez-Estévez, S.E.; Bolaños, M.; Espinosa, E.; González Barón, M. 2002: Phase Ii study of a fixed dose-rate infusion of gemcitabine associated with uracil/tegafur in advanced carcinoma of the pancreas. Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(11): 1756-1762

Shaughnessy, P.J.; Ornstein, D.; Ririe, D.; Callander, N.; Anderson, J.E.; Pollack, M.S.; Freytes, C.O.; Cruz, J.; Rodriquez, T.; Bachier, C.; LeMaistre, C.F. 2002: Phase Ii study of a moderate-intensity preparative regimen with allogeneic peripheral blood stem cell transplantation for hematologic diseases: the Texas Transplant Consortium experience. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 8(8): 420-428

Sakurai, M.; Ichiki, M.; Ohashi, Y.; Hayashi, I. 1993: Phase Ii study of a novel combination regimen composed of cisplatin, carboplatin and etoposide against unresectable non-small cell lung cancer. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(4): 499-502

Evans, W.K.; Earle, C.C.; Stewart, D.J.; Dahrouge, S.; Tomiak, E.; Goss, G.; Logan, D.; Goel, R.; Gertler, S.Z.; Dulude, H. 1997: Phase Ii study of a one hour paclitaxel infusion in combination with carboplatin for advanced non-small cell lung cancer. Lung Cancer 18(1): 83-94

Planting, A.S.; van der Burg, M.E.; Goey, S.H.; Schellens, J.H.; van den Bent, M.J.; de Boer-Dennert, M.; Stoter, G.; Verweij, J. 1995: Phase Ii study of a short course of weekly high-dose cisplatin combined with long-term oral etoposide in pleural mesothelioma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 6(6): 613-615

Hartung, G.; Hofheinz, R.D.; Wein, A.; Riedel, C.; Rost, A.; Fritze, D.; Kreuser, E.D.; Drees, M.; Kühnel, J.; Hehlmann, R.; Queisser, W. 2001: Phase Ii study of a weekly 24-hour infusion with 5-fluorouracil and simultaneous sodium-folinic acid in the first-line treatment of metastatic colorectal cancer. Onkologie 24(5): 457-462

Yang, T.S.; Hsu, K.C.; Wang, H.M.; Lin, Y.C. 2001: Phase Ii study of a weekly 8-hour 5-fluorouracil and leucovorin infusion for patients with advanced colorectal cancer: dose adjusted according to its toxicity. Japanese Journal of Clinical Oncology 31(12): 610-615

Athanasiadis, I.; Kies, M.S.; Miller, M.; Ganzenko, N.; Joob, A.; Marymont, M.; Rademaker, A.; Gradishar, W.J. 1995: Phase Ii study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1(9): 973-979

Westeel, V.; Jacoulet, P.; Breton, J.L.; Garnier, G.; Mercier, M.; Depierre, A. 1996: Phase Ii study of alternating doses of vinorelbine in combination with cisplatin for non-small cell lung cancer (NSCLC): a disappointing experience. Lung Cancer 16(1): 61-73

Alberto, P. 1993: Phase Ii study of an oral combination of doxifluridine, prednimustine and idarubicin (FUPRIDA) for first line treatment of advanced breast cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 4(5): 423-425

Brett, B.T.; Smith, S.C.; Bouvier, C.V.; Michaeli, D.; Hochhauser, D.; Davidson, B.R.; Kurzawinski, T.R.; Watkinson, A.F.; Van Someren, N.; Pounder, R.E.; Caplin, M.E. 2002: Phase Ii study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(20): 4225-4231

Borner, M.M.; Dietrich, D.; Stupp, R.; Morant, R.; Honegger, H.; Wernli, M.; Herrmann, R.; Pestalozzi, B.C.; Saletti, P.; Hanselmann, S.; Müller, S.; Brauchli, P.; Castiglione-Gertsch, M.; Goldhirsch, A.; Roth, A.D. 2002: Phase Ii study of capecitabine and oxaliplatin in first- and second-line treatment of advanced or metastatic colorectal cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(7): 1759-1766

Kim, T.W.; Kang, Y.K.; Ahn, J.H.; Chang, H.M.; Yook, J.H.; Oh, S.T.; Kim, B.S.; Lee, J.S. 2002: Phase Ii study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(12): 1893-1898

Vieitez, J.M.; Valladares, M.; Gracia, M.; Gonzalez-Barón, M.; Martín, G.; Mel, J.R.; Rodríguez, R.; Constenla, M.; Gómez Aldavarí, J.L.; Domínguez, S.; Dorta, J.; García-Girón, C.; López, R.; Sevilla, I.; Esteban, E.; Antón, L.M.; Peláez, I.; López, E.; Lacave, A.J. 2003: Phase Ii study of carboplatin and 1-h intravenous etoposide and paclitaxel in a novel sequence as first-line treatment of patients with small-cell lung cancer. Lung Cancer 39(1): 77-84

Falk, S.J.; Maughan, T.S.; Laurence, V.M.; Lamont, A.; Boote, D.; Ford, J.M.; Osborne, R.J.; Bleehen, N.M. 1993: Phase Ii study of carboplatin and adriamycin as second line chemotherapy in small cell lung cancer. Clinical Oncology 5(2): 85-88

Gururangan, S.; Cavazos, C.M.; Ashley, D.; Herndon, J.E.; Bruggers, C.S.; Moghrabi, A.; Scarcella, D.L.; Watral, M.; Tourt-Uhlig, S.; Reardon, D.; Friedman, H.S. 2002: Phase Ii study of carboplatin in children with progressive low-grade gliomas. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(13): 2951-2958

Rougier, P.; Zarba, J.J.; Ducreux, M.; Basile, M.; Pignon, J.P.; Mahjoubi, M.; Benahmed, M.; Droz, J.P.; Cvitkovic, E.; Armand, J.P. 1993: Phase Ii study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 4(4): 333-336

Feliu, J.; González Barón, M.; García Girón, C.; Espinosa, E.; Vicent, J.M.; Gómez Navarro, J.; Berrocal, A.; Ordóñez, A.; Vilches, Y.; de Castro, J.; Díaz, J. 1996: Phase Ii study of cisplatin, 5-fluorouracil, and leucovorin in inoperable squamous cell carcinoma of the esophagus. ONCOPAZ Cooperative Group, Spain. American Journal of Clinical Oncology 19(6): 577-580

Sakurai, M.; Ichiki, M.; Hayashi, I. 1997: Phase Ii study of combination chemotherapy with cisplatin, carboplatin and etoposide (CPVP) in unresectable non-small cell lung cancer: analysis of survival time and prognostic factors. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 24(3): 303-308

Rosenthal, M.A.; Gruber, M.L.; Glass, J.; Nirenberg, A.; Finlay, J.; Hochster, H.; Muggia, F.M. 2000: Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme. Journal of Neuro-Oncology 47(1): 59-63

Nakata, Y.; Yamada, T.; Itoh, R.; Koishi, K.; Hiraoka, K.; Yamagami, K.; Itani, Y.; Toyoda, S.; Itoh, K.; Kimura, T.; Hosokawa, K.; Honjo, H.; Fujita, H.; Koshiba, H.; Hara, Y.; Tsuchiya, H.; Adachi, S. 2002: Phase Ii study of combination therapy with paclitaxel and carboplatin against postoperative small residual disease in patients with stage i c-IV ovarian cancer--KCOG 989 trial. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(5): 717-722

Hauns, B.; Häring, B.; Köhler, S.; Mross, K.; Unger, C. 2001: Phase II study of combined 5-fluorouracil/ Ginkgo biloba extract (GBE 761 ONC) therapy in 5-fluorouracil pretreated patients with advanced colorectal cancer. PhytoTherapy Research: Ptr 15(1): 34-38

Mori, K.; Kamiyama, Y.; Kondoh, T.; Tominaga, K. 2002: Phase II study of combined Vinorelbine (Navelbine) plus cisplatin for advanced non-small cell lung cancer (an interim report). Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(3): 405-410

Kubota, K.; Tamura, T.; Fukuoka, M.; Furuse, K.; Ikegami, H.; Ariyoshi, Y.; Kurita, Y.; Saijo, N. 2000: Phase Ii study of concurrent chemotherapy and radiotherapy for unresectable stage IIi non-small-cell lung cancer: long-term follow-up results. Japan Clinical Oncology Group Protocol 8902. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(4): 445-450

Hartmann, J.T.; Kanz, L.; Bokemeyer, C. 2000: Phase Ii study of continuous 120-hour-infusion of mitomycin C as salvage chemotherapy in patients with progressive or rapidly recurrent gastrointestinal adenocarcinoma. Anticancer Research 20(2b): 1177-1182

Lopez, M.; Carpano, S.; Cancrini, A.; Marcellini, M.; Del Medico, P.; Rinaldi, M.; Vici, P.; Paoletti, G.; Di Lauro, L. 1993: Phase Ii study of continuous intravenous infusion of recombinant interleukin-2 in patients with advanced renal cell carcinoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 4(8): 689-691

Palumbo, R.; Palmeri, S.; Antimi, M.; Gatti, C.; Raffo, P.; Villani, G.; Toma, S. 1997: Phase Ii study of continuous-infusion high-dose ifosfamide in advanced and/or metastatic pretreated soft tissue sarcomas. Annals of Oncology: Official Journal of the European Society for Medical Oncology 8(11): 1159-1162

Warner, E.; Hedley, D.; Andrulis, I.; Myers, R.; Trudeau, M.; Warr, D.; Pritchard, K.I.; Blackstein, M.; Goss, P.E.; Franssen, E.; Roche, K.; Knight, S.; Webster, S.; Fraser, R.A.; Oldfield, S.; Hill, W.; Kates, R. 1998: Phase Ii study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(6): 1451-1457

Stopeck, A.T.; Jones, A.; Hersh, E.M.; Thompson, J.A.; Finucane, D.M.; Gutheil, J.C.; Gonzalez, R. 2001: Phase Ii study of direct intralesional gene transfer of allovectin-7, an HLA-B7/beta2-microglobulin DNA-liposome complex, in patients with metastatic melanoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(8): 2285-2291

Latreille, J.; Cormier, Y.; Martins, H.; Goss, G.; Fisher, B.; Eisenhauer, E.A. 1996: Phase Ii study of docetaxel (taxotere) in patients with previously untreated extensive small cell lung cancer. Investigational new Drugs 13(4): 343-345

Niho, S.; Ohe, Y.; Kakinuma, R.; Kubota, K.; Matsumoto, T.; Ohmatsu, H.; Goto, K.; Nishiwaki, Y. 2002: Phase Ii study of docetaxel and cisplatin administered as three consecutive weekly infusions for advanced non-small cell lung cancer. Lung Cancer 35(2): 209-214

Kim, Y.H.; Kim, J.S.; Choi, Y.H.; In, K.H.; Park, H.S.; Hong, D.S.; Jeong, T.J.; Lee, Y.Y.; Nam, E.; Lee, S.N.; Lee, K.S.; Kim, H.K. 2002: Phase Ii study of docetaxel and cisplatin combination chemotherapy in metastatic or unresectable localized non-small-cell lung cancer. International Journal of Clinical Oncology 7(2): 114-119

Specht, L.; Larsen, S.K.; Hansen, H.S. 2000: Phase Ii study of docetaxel and cisplatin in patients with recurrent or disseminated squamous-cell carcinoma of the head and neck. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(7): 845-849

Amodio, A.; Carpano, S.; Paoletti, G.; Gionfra, T.; Rinaldi, M.; Manfredi, C.; Foggi, P.; Lopez, M. 1998: Phase Ii study of docetaxel in patients with advanced stage soft tissue sarcoma. La Clinica Terapeutica 149(2): 121-125

Kavanagh, J.J.; Kudelka, A.P.; de Leon, C.G.; Tresukosol, D.; Hord, M.; Finnegan, M.B.; Kim, E.E.; Varma, D.; Forman, A.; Cohen, P.; Edwards, C.L.; Freedman, R.S.; Verschraegen, C.F. 1996: Phase Ii study of docetaxel in patients with epithelial ovarian carcinoma refractory to platinum. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(5): 837-842

Coleman, R.E.; Howell, A.; Eggleton, S.P.; Maling, S.J.; Miles, D.W. 2000: Phase Ii study of docetaxel in patients with liver metastases from breast cancer. UK study group. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(5): 541-546

Mattson, K.; Bosquee, L.; Dabouis, G.; Le Groumellec, A.; Pujol, J.L.; Marien, S.; Stupp, R.; Douillard, J.Y.; Brägas, B.; Berille, J.; Olivares, R.; Le Chevalier, T. 2000: Phase Ii study of docetaxel in the treatment of patients with advanced non-small cell lung cancer in routine daily practice. Lung Cancer 29(3): 205-216

Savarese, D.M.; Halabi, S.; Hars, V.; Akerley, W.L.; Taplin, M.E.; Godley, P.A.; Hussain, A.; Small, E.J.; Vogelzang, N.J. 2001: Phase II study of docetaxel, estramustine, and low-dose hydrocortisone in men with hormone-refractory prostate cancer: a final report of CALGB 9780. Cancer and Leukemia Group B. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 19(9): 2509-2516

Krug, L.M.; Miller, V.A.; Kalemkerian, G.P.; Kraut, M.J.; Ng, K.K.; Heelan, R.T.; Pizzo, B.A.; Perez, W.; McClean, N.; Kris, M.G. 2000: Phase Ii study of dolastatin-10 in patients with advanced non-small-cell lung cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(2): 227-228

Vaishampayan, U.; Glode, M.; Du, W.; Kraft, A.; Hudes, G.; Wright, J.; Hussain, M. 2000: Phase Ii study of dolastatin-10 in patients with hormone-refractory metastatic prostate adenocarcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(11): 4205-4208

Meredith, R.F.; Khazaeli, M.B.; Plott, W.E.; Grizzle, W.E.; Liu, T.; Schlom, J.; Russell, C.D.; Wheeler, R.H.; LoBuglio, A.F. 1996: Phase Ii study of dual 131I-labeled monoclonal antibody therapy with interferon in patients with metastatic colorectal cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 2(11): 1811-1818

Kobayashi, H.; Kawai, S.; Sakayori, S.; Kaneko, M.; Ito, Y.; Ujike, Y.; Kobayashi, K.; Imaizumi, H.; Hoshi, S.; Endo, S. 1994: Phase Ii study of edobacomab (E5) in the treatment of gram-negative sepsis. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 68(1): 81-115

Nisticò, C.; Garufi, C.; Barni, S.; Frontini, L.; Gallà, D.A.; Giannarelli, D.; Vaccaro, A.; D'Ottavio, A.M.; Terzoli, E. 1999: Phase Ii study of epirubicin and vinorelbine with granulocyte colony-stimulating factor: a high-activity, dose-dense weekly regimen for advanced breast cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(8): 937-942

Parnis, F.X.; Olver, I.N.; Kotasek, D.; Norman, J.; Taylor, A.; Russell, J.; Patterson, K.; Keefe, D.; Marafioti, T. 2000: Phase Ii study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(7): 883-884

Cripps, C.; Burnell, M.; Jolivet, J.; Batist, G.; Lofters, W.; Dancey, J.; Iglesias, J.; Fisher, B.; Eisenhauer, E.A. 1999: Phase Ii study of first-line LY231514 (multi-targeted antifolate) in patients with locally advanced or metastatic colorectal cancer: an NCIC Clinical Trials Group study. Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(10): 1175-1179

Tsimberidou, A.M.; O'Brien, S.M.; Cortes, J.E.; Faderl, S.; Andreeff, M.; Kantarjian, H.M.; Keating, M.J.; Giles, F.J. 2002: Phase II study of fludarabine, cytarabine (Ara-C), cyclophosphamide, cisplatin and GM-CSF (FACPGM) in patients with Richter's syndrome or refractory lymphoproliferative disorders. Leukemia and Lymphoma 43(4): 767-772

Epelbaum, R.; Rosenblatt, E.; Nasrallah, S.; Faraggi, D.; Gaitini, D.; Mizrahi, S.; Kuten, A. 2002: Phase Ii study of gemcitabine combined with radiation therapy in patients with localized, unresectable pancreatic cancer. Journal of Surgical Oncology 81(3): 138-143

Von Minckwitz, G.; Bauknecht, T.; Visseren-Grul, C.M.; Neijt, J.P. 1999: Phase Ii study of gemcitabine in ovarian cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(7): 853-855

Sekine, I.; Nishiwaki, Y.; Kakinuma, R.; Kubota, K.; Hojo, F.; Matsumoto, T.; Ohmatsu, H.; Yokozaki, M.; Goto, K.; Miyamoto, T.; Takafuji, J.; Kodama, T. 1997: Phase II study of high-dose dexamethasone-based association in acute and delayed high-dose cisplatin-induced emesis--JCOG study 9413. British Journal of Cancer 76(1): 90-92

Novello, S.; Galli, L.; Antonuzzo, A.; Crinó, L.; Pozzi, E.; Selvaggi, G.; Ricci, S.; Marrocolo, F.; Darwish, S.; Sorbolini, S.; Tonato, M.; Scagliotti, G.V. 2001: Phase Ii study of high-dose paclitaxel and carboplatin in previously untreated, unresectable non-small cell lung cancer. Lung Cancer 34(2): 261-269

Wilailak, S.; Tresukosol, D.; Linasmita, V.; Termrungruanglert, W. 2000: Phase Ii study of high-dose paclitaxel in platinum-refractory epithelial ovarian cancer. European Journal of Gynaecological Oncology 21(6): 610-612

Marschke, R.F.; Grill, J.P.; Sloan, J.A.; Wender, D.B.; Levitt, R.; Mailliard, J.A.; Gerstner, J.B.; Ghosh, C.; Morton, R.F.; Jett, J.R. 1999: Phase Ii study of high-dose somatostatin analogue in patients either previously treated or untreated who have extensive-stage small cell lung cancer. American Journal of Clinical Oncology 22(1): 15-17

Ali, M.A.; Kraut, M.J.; Valdivieso, M.; Herskovic, A.M.; Du, W.; Kalemkerian, G.P. 1998: Phase Ii study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer. Lung Cancer 22(1): 39-44

Thongprasert, S. 2000: Phase Ii study of ifosfamide, carboplatin, etoposide and GM-CSF in small cell lung cancer. Journal of the Medical Association of Thailand 83(5): 549-553

Lichtman, S.M.; Niedzwiecki, D.; Barcos, M.; Carlisle, T.L.; Cooper, M.R.; Johnson, J.L.; Peterson, B.A. 2000: Phase Ii study of infusional chemotherapy with doxorubicin, vincristine and etoposide plus cyclophosphamide and prednisone (I-CHOPE) in resistant diffuse aggressive non-Hodgkin's lymphoma: CALGB 9255. Cancer and Leukemia Group B. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(9): 1141-1146

Gridelli, C.; Perrone, F.; D'Aprile, M.; Rossi, A.; Palmeri, S.; Curcio, C.; Veltri, E.; Ianniello, G.; Lorusso, V.; Palmieri, G. 1995: Phase Ii study of intensive CEV (carboplatin, epirubicin and VP-16) plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer. European Journal of Cancer 31a (13-14): 2424-2426

Meredith, R.F.; Khazaeli, M.B.; Macey, D.J.; Grizzle, W.E.; Mayo, M.; Schlom, J.; Russell, C.D.; LoBuglio, A.F. 1999: Phase Ii study of interferon-enhanced 131I-labeled high affinity CC49 monoclonal antibody therapy in patients with metastatic prostate cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(10 Suppl): 3254s-3258s

Baars, J.W.; Wagstaff, J.; Van Groeningen, C.J.; Vermorken, J.B.; Bijvank, E.M.; Pinedo, H.M.; Nauta, J.J. 1993: Phase Ii study of interferon-gamma and interleukin-2: tachyphylaxis of toxicity to the liver during increasing immune enhancement. Journal of the National Cancer Institute 85(5): 410-411

Lümmen, G.; Goepel, M.; Möllhoff, S.; Hinke, A.; Otto, T.; Rübben, H. 1996: Phase Ii study of interferon-gamma versus interleukin-2 and interferon-alpha 2b in metastatic renal cell carcinoma. Journal of Urology 155(2): 455-458

Vlasveld, L.T.; Horenblas, S.; Hekman, A.; Hilton, A.M.; Dubbelman, A.C.; Melief, C.J.; Rankin, E.M. 1994: Phase Ii study of intermittent continuous infusion of low-dose recombinant interleukin-2 in advanced melanoma and renal cell cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 5(2): 179-181

Dropcho, E.J.; Rosenfeld, S.S.; Vitek, J.; Guthrie, B.L.; Morawetz, R.B. 1998: Phase Ii study of intracarotid or selective intracerebral infusion of cisplatin for treatment of recurrent anaplastic gliomas. Journal of Neuro-Oncology 36(2): 191-198

Hoff, P.M.; Ellerton, J.A.; Dakhil, S.R.; Winn, R.J.; Abbruzzese, J.L.; Pazdur, R. 2000: Phase Ii study of intravenous CI-958 in metastatic colorectal adenocarcinoma. American Journal of Clinical Oncology 23(6): 602-604

Verschraegen, C.F.; Levenback, C.; Vincent, M.; Wolf, J.; Bevers, M.; Loyer, E.; Kudelka, A.P.; Kavanagh, J.J. 2000: Phase II study of intravenous DX-8951f in patients with advanced ovarian, tubal, or peritoneal cancer refractory to platinum, taxane, and topotecan. Annals of the new York Academy of Sciences 922: 349-351

Oh, Y.; Perez-Soler, R.; Fossella, F.V.; Glisson, B.S.; Kurie, J.; Walsh, G.L.; Truong, M.; Shin, D.M. 2000: Phase Ii study of intravenous Doxil in malignant pleural mesothelioma. Investigational new Drugs 18(3): 243-245

Case, D.C.; Gerber, M.C.; Gams, R.A.; Crawford, J.; Votaw, M.L.; Higano, C.S.; Pruitt, B.T.; Gould, J. 1993: Phase Ii study of intravenous idarubicin in unfavorable non-Hodgkin's lymphoma. Leukemia and Lymphoma 10 Suppl: 73-79

Watanabe, N.; Miyagawa, I.; Higasibori, Y.; Nakahara, T.; Sumi, F.; Ishida, G.; Abe, B.; Inoue, A.; Hanamoto, N. 1994: Phase II study of intravesical chemoprophylaxis of epirubicin after transurethral resection of bladder tumors. Tottori University Oncology Group. Cancer ChemoTherapy and Pharmacology 35 Suppl: S57-S59

Turner, C.D.; Gururangan, S.; Eastwood, J.; Bottom, K.; Watral, M.; Beason, R.; McLendon, R.E.; Friedman, A.H.; Tourt-Uhlig, S.; Miller, L.L.; Friedman, H.S. 2002: Phase II study of irinotecan (CPT-11) in children with high-risk malignant brain tumors: the Duke experience. Neuro-Oncology 4(2): 102-108

Takeda, K.; Takifuji, N.; Uejima, H.; Yoshimura, N.; Terakawa, K.; Negoro, S. 2002: Phase II study of irinotecan and carboplatin for advanced non-small cell lung cancer. Lung Cancer 38(3): 303-308

Kudoh, S.; Fujiwara, Y.; Takada, Y.; Yamamoto, H.; Kinoshita, A.; Ariyoshi, Y.; Furuse, K.; Fukuoka, M. 1998: Phase II study of irinotecan combined with cisplatin in patients with previously untreated small-cell lung cancer. West Japan Lung Cancer Group. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(3): 1068-1074

Furukawa, H.; Hiratsuka, M.; Imaoka, S.; Ishikawa, O.; Kabuto, T.; Sasaki, Y.; Kameyama, M.; Ohigashi, H.; Nakano, H.; Yasuda, T.; Murata, K. 1999: Phase II study of limited surgery for early gastric cancer: segmental gastric resection. Annals of Surgical Oncology 6(2): 166-170

Verweij, J.; Judson, I.; Steward, W.; Coleman, R.; Woll, P.; van Pottelsberghe, C.; van Glabbeke, M.; Mouridsen, H. 1994: Phase Ii study of liposomal muramyl tripeptide phosphatidylethanolamine (MTP/PE) in advanced soft tissue sarcomas of the adult. An EORTC Soft Tissue and Bone Sarcoma Group study. European Journal of Cancer 30a (6): 842-843

Stewart, D.J.; Eapen, L.; Girard, A.; Verma, S.; Genest, P.; Evans, W.K. 1993: Phase Ii study of lonidamine plus radiotherapy in the treatment of brain metastases. Journal of Neuro-Oncology 15(1): 19-22

Smorenburg, C.H.; Seynaeve, C.; Bontenbal, M.; Planting, A.S.; Sindermann, H.; Verweij, J. 2000: Phase Ii study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients. Anti-Cancer Drugs 11(10): 825-828

Wiernik, P.H.; Moore, D.F.; Bennett, J.M.; Vogl, S.E.; Harris, J.E.; Luger, S.; Oken, M.M.; Glick, J.H. 1998: Phase Ii study of mitoguazone, cyclophosphamide, doxorubicin, vincristine and prednisone for patients with diffuse histologic subtypes of non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Study (PE481). Leukemia and Lymphoma 30(5-6): 601-607

Kikuyama, S.; Inada, T.; Oyama, R.; Ogata, Y. 2002: Phase Ii study of mitomycin C, cisplatin and 5-fluorouracil for advanced and recurrent gastric cancer. Anticancer Research 22(6b): 3633-3636

Pusztai, L.; Holmes, F.A.; Fraschini, G.; Hortobagyi, G.N. 1999: Phase Ii study of mitoxantrone by 14-day continuous infusion with granulocyte colony-stimulating factor (GCSF) support in patients with metastatic breast cancer and limited prior therapy. Cancer ChemoTherapy and Pharmacology 43(1): 86-91

Mammoliti, S.; Merlini, L.; Caroti, C.; Gallo, L. 1996: Phase Ii study of mitoxantrone, 5-fluorouracil, and levo-leucovorin (MLF) in elderly advanced breast cancer patients. Breast Cancer Research and Treatment 37(1): 93-96

Grossi, F.; Pennucci, M.C.; Serrano, J.; Frola, C.; Mereu, C.; Scolaro, T.; Ratto, G.B.; Tixi, L.; Ardizzoni, A. 2002: Phase Ii study of neoadjuvant chemotherapy in patients with surgically-proven, unresectable stage IIi non-small cell lung cancer. Anticancer Research 22(6b): 3519-3524

Buzaid, A.C.; Colome, M.; Bedikian, A.; Eton, O.; Legha, S.S.; Papadopoulos, N.; Plager, C.; Ross, M.; Lee, J.E.; Mansfield, P.; Rice, J.; Ring, S.; Lee, J.J.; Strom, E.; Benjamin, R. 1998: Phase Ii study of neoadjuvant concurrent biochemotherapy in melanoma patients with local-regional metastases. Melanoma Research 8(6): 549-556

Pujol, J.L.; Monnier, A.; Berille, J.; Cerrina, M.L.; Douillard, J.Y.; Rivière, A.; Grandgirard, A.; Gouva, S.; Bizzari, J.P.; Le Chevalier, T. 1994: Phase II study of nitrosourea fotemustine as single-drug chemotherapy in poor-prognosis non-small-cell lung cancer. British Journal of Cancer 69(6): 1136-1140

Van der Gaast, A.; Henzen-Logmans, S.C.; Planting, A.S.; Stoter, G.; Verweij, J. 1993: Phase Ii study of oral administration of etoposide for patients with well- and moderately-differentiated adenocarcinomas of unknown primary site. Annals of Oncology: Official Journal of the European Society for Medical Oncology 4(9): 789-790

Cartwright, T.H.; Cohn, A.; Varkey, J.A.; Chen, Y.-M.; Szatrowski, T.P.; Cox, J.V.; Schulz, J.J. 2002: Phase Ii study of oral capecitabine in patients with advanced or metastatic pancreatic cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(1): 160-164

Lin, J.K.; Wang, W.S.; Hsieh, R.K.; Hsu, T.C.; Chiou, T.J.; Liu, J.H.; Fan, F.S.; Yen, C.C.; Lin, T.C.; Jiang, J.K.; Yang, S.H.; Wang, H.S.; Chen, P.M. 2000: Phase Ii study of oral tegafur-uracil and folinic acid as first-line therapy for metastatic colorectal cancer: Taiwan experience. Japanese Journal of Clinical Oncology 30(11): 510-514

White, S.C.; Cheeseman, S.; Thatcher, N.; Anderson, H.; Carrington, B.; Hearn, S.; Ross, G.; Ranson, M. 2000: Phase Ii study of oral topotecan in advanced non-small cell lung cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(3): 868-873

Freyer, G.; Delozier, T.; Lichinister, M.; Gedouin, D.; Bougnoux, P.; His, P.; Imadalou, K.; Trillet-Lenoir, V. 2003: Phase Ii study of oral vinorelbine in first-line advanced breast cancer chemotherapy. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21(1): 35-40

Zelek, L.; Cottu, P.; Tubiana-Hulin, M.; Vannetzel, J-M.; Chollet, P.; Misset, J-L.; Chouaki, N.; Marty, M.; Gamelin, E.; Culine, S.; Dieras, V.; Mackenzie, S.; Spielmann, M. 2002: Phase II study of oxaliplatin and fluorouracil in taxane- and anthracycline-pretreated breast cancer patients. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(10): 2551-2558

Monnet, I.; Brienza, S.; Hugret, F.; Voisin, S.; Gastiaburu, J.; Saltiel, J.C.; Soulié, P.; Armand, J.P.; Cvitkovic, E.; de Cremoux, H. 1998: Phase II study of oxaliplatin in poor-prognosis non-small cell lung cancer (NSCLC). ATTIT. Association pour le Traitement des Tumeurs Intra Thoraciques. European Journal of Cancer 34(7): 1124-1127

Louvet, C.; André, T.; Tigaud, J.M.; Gamelin, E.; Douillard, J.Y.; Brunet, R.; François, E.; Jacob, J.H.; Levoir, D.; Taamma, A.; Rougier, P.; Cvitkovic, E.; de Gramont, A. 2002: Phase Ii study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(23): 4543-4548

Noda, K.; Ikeda, M.; Kudo, R.; Nishiya, I.; Yajima, A.; Tanaka, K.; Kodama, S.; Takahashi, T.; Tokunaga, A.; Satoh, I.; Nozawa, S.; Taketani, Y.; Terashima, Y.; Isonishi, S.; Takeda, Y.; Nishijima, M.; Kuroshima, Y.; Fujii, S.; Izumi, R.; Tamaya, T.; Mori, T.; Okada, H.; Ogita, S.; Ozaki, M.; Hatae, M. 1996: Phase Ii study of paclitaxel (BMS-181339) in patients with ovarian cancer by 3-hour intravenous infusion. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(3): 317-325

Chen, C.-H.; Chang, W.-C.; Lin, M.-C.; Hsu, J.-W.; Chao, T.-Y.; Tsao, T.C.Y. 2002: Phase Ii study of paclitaxel (Genaxol) and cisplatin combination in treating Chinese patients with advanced non-small cell lung cancer (NSCLC). Lung Cancer 38(1): 91-96

Thongprasert, S. 1998: Phase Ii study of paclitaxel (Taxol) and ifosfamide (Holoxan) in inoperable non-small-cell lung cancer. Lung Cancer 19(3): 185-189

Laohavinij, S.; Maoleekoonpairoj, S.; Cheirsilpa, A.; Maneechavakajorn, J.; Sirachainant, E.; Arpornvivat, W.; Jaisathaporn, K.; Ratanatharathorn, V. 1999: Phase Ii study of paclitaxel and carboplatin for advanced non-small-cell lung cancer. Lung Cancer 26(3): 175-185

Lück, H.J.; Thomssen, C.; du Bois, A.; Untch, M.; Lisboa, B.; Köhler, G.; Diergarten, K. 1997: Phase Ii study of paclitaxel and epirubicin as first-line therapy in patients with metastatic breast cancer. Seminars in Oncology 24(5 Suppl 17: S17

Boyer, M.J.; Mitchell, P.; Goldstein, D.; Millward, M.J.; Olver, I.N.; Clarke, S.J.; Richardson, G.; Davis, I. 2001: Phase Ii study of paclitaxel and oral etoposide in patients with locally advanced or metastatic non-small cell lung cancer. Lung Cancer 32(1): 89-94

Lissoni, A.; Zanetta, G.; Losa, G.; Gabriele, A.; Parma, G.; Mangioni, C. 1996: Phase Ii study of paclitaxel as salvage treatment in advanced endometrial cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 7(8): 861-863

Rivera, E.; Holmes, F.A.; Frye, D.; Valero, V.; Theriault, R.L.; Booser, D.; Walters, R.; Buzdar, A.U.; Dhingra, K.; Fraschini, G.; Hortobagyi, G.N. 2000: Phase Ii study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy. Cancer 89(11): 2195-2201

Bokemeyer, C.; Beyer, J.; Metzner, B.; Ruther, U.; Harstrick, A.; Weissbach, L.; Kohrmann, U.; Verbeek, W.; Schmoll, H.J. 1996: Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 7(1): 31-34

Yamaguchi, K.; Tada, M.; Horikoshi, N.; Otani, T.; Takiuchi, H.; Saitoh, S.; Kanamaru, R.; Kasai, Y.; Koizumi, W.; Sakata, Y.; Taguchi, T. 2002: Phase Ii study of paclitaxel with 3-h infusion in patients with advanced gastric cancer. Gastric Cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 5(2): 90-95

Harrington, K.J.; Lewanski, C.; Northcote, A.D.; Whittaker, J.; Peters, A.M.; Vile, R.G.; Stewart, J.S. 2001: Phase Ii study of pegylated liposomal doxorubicin (Caelyx) as induction chemotherapy for patients with squamous cell cancer of the head and neck. European Journal of Cancer 37(16): 2015-2022

Samantas, E.; Kalofonos, H.; Linardou, H.; Nicolaides, C.; Mylonakis, N.; Fountzilas, G.; Kosmidis, P.; Skarlos, D. 2000: Phase Ii study of pegylated liposomal doxorubicin: inactive in recurrent small-cell lung cancer. a Hellenic Cooperative Oncology Group Study. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(11): 1395-1397

De Wit, R.; van der Burg, M.E.; van den Gaast, A.; Logmans, A.; Stoter, G.; Verweij, J. 1994: Phase Ii study of prolonged oral etoposide in patients with ovarian cancer refractory to or relapsing within 12 months after platinum-containing chemotherapy. Annals of Oncology: Official Journal of the European Society for Medical Oncology 5(7): 656-657

Kavanagh, J..J..; Tresukosol, D..; De Leon, C.. G.; Edwards, C..L..; Freedman, R..S..; Hord, M..; Howell, E..; Lenzi, R..; Krakoff, I..H..; Kudelka, A..P.. 1995: Phase Ii study of prolonged oral etoposide in refractory ovarian cancer. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 5(5): 351-354

Fulton, D.; Urtasun, R.; Forsyth, P. 1996: Phase Ii study of prolonged oral therapy with etoposide (VP16) for patients with recurrent malignant glioma. Journal of Neuro-Oncology 27(2): 149-155

De Vries, M.J.; Schilder, J.N.; Mulder, C.L.; Vrancken, A.M.; Remie, M.; Garssen, B. 1997: Phase Ii study of psychotherapeutic intervention in advanced cancer. Psycho-Oncology 6(2): 129-137

Blay, J.Y.; Judson, I.; Rodenhuis, S.; Hermans, C.; Smith, M.; van Glabbeke, M.; Verweij, J. 1999: Phase Ii study of raltitrexed ('Tomudex') for patients with advanced soft tissue sarcomas refractory to doxorubicin-containing regimens. Anti-Cancer Drugs 10(10): 873-877

Sato, A.; Kurihara, M.; Horikoshi, N.; Aiba, K.; Kikkawa, N.; Shirouzu, K.; Mitachi, Y.; Sakata, Y.; Wakui, A. 1999: Phase Ii study of raltitrexed (Tomudex) in chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study Group. Anti-Cancer Drugs 10(8): 741-748

Walters, R.S.; Theriault, R.L.; Booser, D.J.; Esparza, L.; Hortobagyi, G.N. 1995: Phase Ii study of recombinant alpha-interferon (rIFN alpha) and continuous-infusion 5-fluorouracil in metastatic breast cancer. Journal of ImmunoTherapy with Emphasis on Tumor Immunology: Official Journal of the Society for Biological Therapy 18(3): 185-187

Worth, L.L.; Jaffe, N.; Benjamin, R.S.; Papadopoulos, N.E.; Patel, S.; Raymond, A.K.; Jia, S.F.; Rodriguez, C.; Gano, J.; Gianan, M.A.; Kleinerman, E.S. 1997: Phase Ii study of recombinant interleukin 1alpha and etoposide in patients with relapsed osteosarcoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 3(10): 1721-1729

Chen, S.C.; Lin, M.C.; Chang, J.W.; Wang, S.W.; Lee, C.H.; Tsao, T.C. 2000: Phase Ii study of regimen of gemcitabine and cisplatin in advanced non-small cell lung cancer. Japanese Journal of Clinical Oncology 30(11): 494-498

Verweij, J.; Wanders, J.; Gil, T.; Schöffski, P.; Catimel, G.; te Velde, A.; de Mulder, P.H. 1996: Phase II study of rhizoxin in squamous cell head and neck cancer. The EORTC Early Clinical Trials Group. British journal of cancer 73(3): 400-402

Roelofs, E.J.; Wagener, D.J.; Conroy, T.; Wils, J.; Burghouts, J.T.; Fickers, M.; de Graeff, A.; Lalisang, F.; Paillot, B. 1993: Phase Ii study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 4(5): 426-428

Takahashi, S.; Kinoshita, T.; Konishi, M.; Nakagouri, T.; Inoue, K.; Ono, M.; Sugitou, M.; Ohtsu, A.; Boku, N.; Yoshida, S. 2001: Phase Ii study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer. Gastric Cancer: Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association 4(4): 192-197

Crump, M.; Couban, S.; Meyer, R.; Rudinskas, L.; Zanke, B.; Gluck, S.; Maksymiuk, A.; Hoskins, P.; Matthews, S.; Eisenhauer, E. 2002: Phase II study of sequential topotecan and etoposide in patients with intermediate grade non-Hodgkin's lymphoma: a National Cancer Institute of Canada Clinical Trials Group study. Leukemia and Lymphoma 43(8): 1581-1587

Belch, A.R.; Eisenhauer, E.A.; Muldal, A.; Browman, G.; Klasa, R.; Osterwalder, B. 1995: Phase Ii study of subcutaneous rHu-interleukin-2 and rHu-interferon alpha-2a in previously treated patients with multiple myeloma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 6(7): 721-723

Dawson, N.; Figg, W.D.; Brawley, O.W.; Bergan, R.; Cooper, M.R.; Senderowicz, A.; Headlee, D.; Steinberg, S.M.; Sutherland, M.; Patronas, N.; Sausville, E.; Linehan, W.M.; Reed, E.; Sartor, O. 1998: Phase Ii study of suramin plus aminoglutethimide in two cohorts of patients with androgen-independent prostate cancer: simultaneous antiandrogen withdrawal and prior antiandrogen withdrawal. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(1): 37-44

Chen, Y.; Perng, R.P.; Yang, K.Y.; Lin, W.C.; Wu, H.W.; Tsai, C.M.; Whang-Peng, J. 2000: Phase Ii study of tamoxifen, ifosfamide, epirubicin and cisplatin combination chemotherapy in patients with non-small cell lung cancer failing previous chemotherapy. Lung Cancer 29(2): 139-146

Christodoulou, C.; Bafaloukos, D.; Kosmidis, P.; Samantas, E.; Bamias, A.; Papakostas, P.; Karabelis, A.; Bacoyiannis, C.; Skarlos, D.V. 2001: Phase Ii study of temozolomide in heavily pretreated cancer patients with brain metastases. Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(2): 249-254

Marx, G.M.; Pavlakis, N.; McCowatt, S.; Boyle, F.M.; Levi, J.A.; Bell, D.R.; Cook, R.; Biggs, M.; Little, N.; Wheeler, H.R. 2001: Phase Ii study of thalidomide in the treatment of recurrent glioblastoma multiforme. Journal of Neuro-Oncology 54(1): 31-38

Clerici, M.; De Marinis, F.; Piazza, E.; Frontini, L.; Tucci, E.; Barni, S.; Bretti, S.; Luporini, G.; Intini, C. 1998: Phase Ii study of the activity and tolerability of a combined regimen of high-dose epirubicin and cisplatin in stage IIIb and IV non-small cell lung cancer. Tumori 84(6): 669-672

Ten Bokkel Huinink, W.W.; van Warmerdam, L.J.; Helmerhorst, T.J.; Schaefers, M.C.; Beijnen, J.H.; Rodenhuis, S. 1997: Phase Ii study of the combination carboplatin and paclitaxel in patients with ovarian cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 8(4): 351-354

Miller, V.A.; Ng, K.K.; Grant, S.C.; Kindler, H.; Pizzo, B.; Heelan, R.T.; von Roemeling, R.; Kris, M.G. 1997: Phase Ii study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 8(12): 1269-1271

Miller, K.D.; Picus, J.; Blanke, C.; John, W.; Clark, J.; Shulman, L.N.; Thornton, D.; Rowinsky, E.; Loehrer, P.J. 2000: Phase Ii study of the multitargeted antifolate LY231514 (ALIMTA, MTA, pemetrexed disodium) in patients with advanced pancreatic cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(1): 101-103

Stewart, D.J.; Eisenhauer, E.; Macdonald, D.R.; Cairncross, J.G.; Langleben, A. 1993: Phase II study of tiazofurin in gliomas in adults. A National Cancer Institute of Canada study. Journal of Neuro-Oncology 15(2): 175-179

Bramwell, V.H.; Eisenhauer, E.A.; Blackstein, M.; Boos, G.; Knowling, M.; Jolivet, J.; Bogues, W. 1995: Phase Ii study of topotecan (NSC 609 699) in patients with recurrent or metastatic soft tissue sarcoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 6(8): 847-849

Macdonald, D.; Cairncross, G.; Stewart, D.; Forsyth, P.; Sawka, C.; Wainman, N.; Eisenhauer, E. 1996: Phase II study of topotecan in patients with recurrent malignant glioma. National Clinical Institute of Canada Clinical Trials Group. Annals of oncology: official journal of the European Society for Medical Oncology 7(2): 205-207

Giles, F.J.; Garcia-Manero, G.; Cortes, J.E.; Baker, S.D.; Miller, C.B.; O'Brien, S.M.; Thomas, D.A.; Andreeff, M.; Bivins, C.; Jolivet, J.; Kantarjian, H.M. 2002: Phase Ii study of troxacitabine, a novel dioxolane nucleoside analog, in patients with refractory leukemia. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(3): 656-664

Sekine, I.; Nishiwaki, Y.; Ogino, T.; Yokoyama, A.; Saito, M.; Mori, K.; Tsukiyama, I.; Tsuchiya, S.; Hayakawa, K.; Yoshimura, K.; Ishizuka, N.; Saijo, N. 2002: Phase Ii study of twice-daily high-dose thoracic radiotherapy alternating with cisplatin and vindesine for unresectable stage IIi non-small-cell lung cancer: Japan Clinical Oncology Group Study 9306. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(3): 797-803

Vermorken, J.. B..; Mangioni, C..; Pecorelli, S..; Van Der Burg, M.. E.. L..; Van Oosterom, A.. T..; Ten Bokkel Huinink, W.. W..; Rotmensz, N..; Dalesio, O.. 2000: Phase Ii study of vincristine, bleomycin, mitomycin C and cisplatin (VBMP) in disseminated squamous cell carcinoma of the uterine cervix. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 10(5): 358-365

Jassem, J.; Karnicka-Młodkowska, H.; van Pottelsberghe, C.; van Glabbeke, M.; Noseda, M.A.; Ardizzoni, A.; Gozzelino, F.; Planting, A.; van Zandwijk, N. 1993: Phase Ii study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients. EORTC Lung Cancer Cooperative Group. European Journal of Cancer 29a (12): 1720-1722

Isokangas, O.P.; Knuuttila, A.; Halme, M.; Mäntylä, M.; Lindström, I.; Nikkanen, V.; Viren, M.; Joensuu, H.; Mattson, K. 1999: Phase Ii study of vinorelbine and gemcitabine for inoperable stage IIIB-IV non-small-cell lung cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(9): 1059-1063

Furuse, K.; Kubota, K.; Kawahara, M.; Takada, M.; Kimura, I.; Fujii, M.; Ohta, M.; Hasegawa, K.; Yoshida, K.; Nakajima, S.; Ogura, T.; Niitani, H. 1996: Phase Ii study of vinorelbine in heavily previously treated small cell lung cancer. Japan Lung Cancer Vinorelbine Study Group. Oncology 53(2): 169-172

Oudard, S.; Caty, A.; Humblet, Y.; Beauduin, M.; Suc, E.; Piccart, M.; Rolland, F.; Fumoleau, P.; Bugat, R.; Houyau, P.; Monnier, A.; Sun, X.; Montcuquet, P.; Breza, J.; Novak, J.; Gil, T.; Chopin, D. 2001: Phase Ii study of vinorelbine in patients with androgen-independent prostate cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(6): 847-852

Baldini, E.; Tibaldi, C.; Chella, A.; Angeletti, C.A.; Silvano, G.; Andrei, A.; Algeri, R.; Conte, P.F. 1996: Phase Ii study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 7(7): 747-749

Goss, P.E.; Clark, R.M.; Ambus, U.; Weizel, H.A.; Wadden, N.A.; Crump, M.; Walde, D.; Tye, L.M.; De Coster, R.; Bruynseels, J. 1995: Phase Ii study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1(3): 287-294

Lorenz, M.; Mueller, H.H.; Mattes, E.; Gassel, H.J.; Junginger, T.; Saeger, H.D.; Schramm, H.; Staib-Sebler, E.; Vetter, G.; Heinrich, S.; Köhne, C.H. 2001: Phase Ii study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal carcinomas. Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(3): 321-325

Esteva, F.J.; Valero, V.; Booser, D.; Guerra, L.T.; Murray, J.L.; Pusztai, L.; Cristofanilli, M.; Arun, B.; Esmaeli, B.; Fritsche, H.A.; Sneige, N.; Smith, T.L.; Hortobagyi, G.N. 2002: Phase Ii study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(7): 1800-1808

Aihara, T.; Kim, Y.; Takatsuka, Y. 2002: Phase Ii study of weekly docetaxel in patients with metastatic breast cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(2): 286-292

Beer, T.M.; Pierce, W.C.; Lowe, B.A.; Henner, W.D. 2001: Phase Ii study of weekly docetaxel in symptomatic androgen-independent prostate cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(9): 1273-1279

Van den Bent, M.J.; Pronk, L.; Sillevis Smitt, P.A.; Vecht, C.J.; Eskens, F.A.; Verweij, J. 1999: Phase Ii study of weekly dose-intensified cisplatin chemotherapy with oral etoposide in recurrent glioma. Journal of Neuro-Oncology 44(1): 59-64

Baselga, J.; Tripathy, D.; Mendelsohn, J.; Baughman, S.; Benz, C.C.; Dantis, L.; Sklarin, N.T.; Seidman, A.D.; Hudis, C.A.; Moore, J.; Rosen, P.P.; Twaddell, T.; Henderson, I.C.; Norton, L. 1999: Phase Ii study of weekly intravenous trastuzumab (Herceptin) in patients with HER2/neu-overexpressing metastatic breast cancer. Seminars in Oncology 26(4 Suppl 12: 78-83

Naka, N.; Kawahara, M.; Okishio, K.; Hosoe, S.; Ogawara, M.; Atagi, S.; Takemoto, Y.; Ueno, K.; Kawaguchi, T.; Tsuchiyama, T.; Furuse, K. 2002: Phase II study of weekly irinotecan and carboplatin for refractory or relapsed small-cell lung cancer. Lung Cancer 37(3): 319-323

Aghajanian, C.; Fennelly, D.; Shapiro, F.; Waltzman, R.; Almadrones, L.; O'Flaherty, C.; O'Conner, K.; Venkatraman, E.; Barakat, R.; Curtin, J.; Brown, C.; Reich, L.; Wuest, D.; Norton, L.; Hoskins, W.; Spriggs, D.R. 1998: Phase Ii study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(5): 1852-1860

Verweij, J.; de Mulder, P.H.; de Graeff, A.; Vermorken, J.B.; Wildiers, J.; Kerger, J.; Schornagel, J.; Cognetti, F.; Kirkpatrick, A.; Sahmoud, T.; Lefebvre, J.L. 1996: Phase Ii study on mitoxantrone in adenoid cystic carcinomas of the head and neck. EORTC Head and Neck Cancer Cooperative Group. Annals of Oncology: Official Journal of the European Society for Medical Oncology 7(8): 867-869

Rau, B.; Wust, P.; Gellermann, J.; Tilly, W.; Hünerbein, M.; Löffel, J.; Stahl, H.; Riess, H.; Budach, V.; Felix, R.; Schlag, P. 1998: Phase Ii study on preoperative radio-chemo-thermotherapy in locally advanced rectal carcinoma. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 174(11): 556-565

Van Hoesel, Q.G.; Verweij, J.; Catimel, G.; Clavel, M.; Kerbrat, P.; van Oosterom, A.T.; Kerger, J.; Tursz, T.; van Glabbeke, M.; van Pottelsberghe, C. 1994: Phase Ii study with docetaxel (Taxotere) in advanced soft tissue sarcomas of the adult. EORTC Soft Tissue and Bone Sarcoma Group. Annals of Oncology: Official Journal of the European Society for Medical Oncology 5(6): 539-542

Chen, Y.M.; Perng, R.P.; Whang-Peng, J.; Wu, H.W.; Lin, W.C.; Tsai, C.M. 2000: Phase Ii study with gemcitabine, ifosfamide and cisplatin in advanced non-small cell lung cancer. Lung Cancer 30(3): 199-202

Villar-Grimalt, A.; Aranda, E.; Massutí, B.; Belón, J.; Antón, A.; Jimeno, J.M.; Candel, M.T.; García de Paredes, M.L.; Colajori, E. 1994: Phase II study with iododoxorubicin in measurable advanced colorectal adenocarcinoma. Effective rescue using weekly high-dose 5-fluorouracil (WFU). Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD), Work Group of SEOM (Spanish Medical Oncology Society). Tumori 80(2): 124-127

Maoleekoonpairoj, S.; Phromratanapongse, P.; Puttanuparp, S. 1997: Phase Ii study: concurrent chemo-radiotherapy in advanced nasopharyngeal carcinoma. Journal of the Medical Association of Thailand 80(12): 778-784

Fletcher, J.L. 2001: Phase Ii temporomandibular joint disorder treatment. Functional Orthodontist 18(3): 14-17

Kucuk, O.; Young, M.L.; Habermann, T.M.; Wolf, B.C.; Jimeno, J.; Cassileth, P.A. 2000: Phase Ii trail of didemnin B in previously treated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group (ECOG) Study. American Journal of Clinical Oncology 23(3): 273-277

Esteva, F.J.; Soh, L.T.; Holmes, F.A.; Plunkett, W.; Meyers, C.A.; Forman, A.D.; Hortobagyi, G.N. 2000: Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer. Cancer ChemoTherapy and Pharmacology 46(5): 382-386

Antón, A.; Díaz-Fernández, N.; González Larriba, J.L.; Vadell, C.; Masutti, B.; Montalar, J.; Barneto, I.; Artal, A.; Rosell, R. 1998: Phase Ii trial assessing the combination of gemcitabine and cisplatin in advanced non-small cell lung cancer (NSCLC). Lung Cancer 22(2): 139-148

Hasbini, A.; Mahjoubi, R.; Fandi, A.; Chouaki, N.; Taamma, A.; Lianes, P.; Cortès-Funes, H.; Alonso, S.; Armand, J.P.; Cvitkovic, E.; Raymond, E. 1999: Phase Ii trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngeal type. Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(4): 421-425

Hsu, C.; Huang, C-Sheng.; Chao, T-Yi.; Lu, Y-Shen.; Bu, C-Fang.; Chen, M.M.; Chang, K-Jeng.; Cheng, A-Lii. 2002: Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma. Cancer 95(10): 2044-2050

Jeanfaivre, T.; Souday, V.; Chaleil, D.; Maillet, F.; Tuchais, E. 2000: Phase Ii trial evaluating the effect of megestrol acetate-prednisolone combination in the treatment of anorexia during the palliative-care phase of lung cancer. Revue de Pneumologie Clinique 56(4): 255-260

Guastalla, J.P.; Vermorken, J.B.; Wils, J.A.; George, M.; Scotto, V.; Nooij, M.; ten Bokkel Huinnink, W.W.; Dalesio, O.; Renard, J. 1994: Phase Ii trial for intraperitoneal cisplatin plus intravenous sodium thiosulphate in advanced ovarian carcinoma patients with minimal residual disease after cisplatin-based chemotherapy--a phase Ii study of the EORTC Gynaecological Cancer Cooperative Group. European Journal of Cancer 30a (1): 45-49

Jiao, X.; Liu, G.Y.; Shan, C.O.; Zhao, X.; Li, X.W.; Gathmann, I.; Royce, C. 1997: Phase II trial in China of a new, rapidly-acting and effective oral antimalarial, CGP 56697, for the treatment of Plasmodium falciparum malaria. Southeast Asian Journal of Tropical Medicine and Public Health 28(3): 476-481

Cascinu, S.; Del Ferro, E.; Ligi, M.; Graziano, F.; Castellani, A.; Catalano, G. 1996: Phase Ii trial of 13-cis retinoic acid plus interferon-alpha in advanced squamous cell carcinoma of head and neck, refractory to chemotherapy. Annals of Oncology: Official Journal of the European Society for Medical Oncology 7(5): 538

Arnold, A.; Ayoub, J.; Douglas, L.; Hoogendoorn, P.; Skingley, L.; Gelmon, K.; Hirsh, V.; Eisenhauer, E. 1994: Phase II trial of 13-cis-retinoic acid plus interferon alpha in non-small-cell lung cancer. The National Cancer Institute of Canada Clinical Trials Group. Journal of the National Cancer Institute 86(4): 306-309

Rothenberg, M.L.; Benedetti, J.K.; Macdonald, J.S.; Seay, T.E.; Neubauer, M.A.; George, C.S.; Tanaka, M.S.; Giguere, J.K.; Pruitt, B.T.; Abbruzzese, J.L. 2002: Phase Ii trial of 5-fluorouracil plus eniluracil in patients with advanced pancreatic cancer: a Southwest Oncology Group study. Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(10): 1576-1582

Ravandi, F.; Rytting, M.E.; Osmon, C.; Braud, E.L.; Roach, R.W.; Edwards, K.; Winn, R.; Abbruzzese, J.L.; Pazdur, R. 1999: Phase Ii trial of 5-fluorouracil, folinic acid and recombinant alpha-2a-interferon in patients with advanced colorectal cancer. Anti-Cancer Drugs 10(6): 519-524

André, T.; Lotz, J.P.; Bouleuc, C.; Azzouzi, K.; Houry, S.; Hannoun, L.; See, J.; Esteso, A.; Avenin, D.; Izrael, V. 1996: Phase Ii trial of 5-fluorouracil, leucovorin and cisplatin for treatment of advanced pancreatic adenocarcinoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 7(2): 173-178

Pazdur, R.; Medgyesy, D.C.; Winn, R.J.; Dakhil, S.R.; Moore, D.F.; Scalzo, A.; Hoff, P.M.; Arbuck, S.G.; Abbruzzese, J.L. 1998: Phase Ii trial of 9-aminocamptothecin (NSC 603071) administered as a 120-hr continuous infusion weekly for three weeks in metastatic colorectal carcinoma. Investigational new Drugs 16(4): 341-346

Whitehead, R.P.; Unger, J.M.; Flaherty, L.E.; Eckardt, J.R.; Taylor, S.A.; Didolkar, M.S.; Samlowski, W.; Sondak, V.K. 2001: Phase Ii trial of CI-980 in patients with disseminated malignant melanoma and no prior chemotherapy. a Southwest Oncology Group study. Investigational new Drugs 19(3): 239-243

Celik, I.; Kars, A.; Güler, N.; Barişta, I.; Tekuzman, G.; Ozyilkan, O.; Hayran, M.; Firat, D. 1998: Phase Ii trial of MINE as a front-line therapeutic modality in intermediate- and high-grade non-Hodgkin's lymphomas. European Journal of Cancer 34(5): 759-760

Khoo, K.; Brandes, L.; Reyno, L.; Arnold, A.; Dent, S.; Vandenberg, T.; Lebwohl, D.; Fisher, B.; Eisenhauer, E. 1999: Phase II trial of N,N-diethyl-2-[4-(phenylmethyl)phenoxy]ethanamine.HCl and doxorubicin chemotherapy in metastatic breast cancer: A National Cancer Institute of Canada clinical trials group study. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 17(11): 3431-3437

Brown, K.S.; Levitt, D.J.; Shannon, M.; Link, B.K. 2001: Phase Ii trial of Remitogen (humanized 1D10) monoclonal antibody targeting class Ii in patients with relapsed low-grade or follicular lymphoma. Clinical Lymphoma 2(3): 188-190

Pazdur, R.; Meropol, N.J.; Casper, E.S.; Fuchs, C.; Douglass, H.O.; Vincent, M.; Abbruzzese, J.L. 1996: Phase Ii trial of ZD1694 (Tomudex) in patients with advanced pancreatic cancer. Investigational new Drugs 13(4): 355-358

Tan, E.H.; Khoo, K.S.; Wee, J.; Fong, K.W.; Lee, K.S.; Lee, K.M.; Chua, E.T.; Tan, T.; Khoo-Tan, H.S.; Yang, T.L.; Au, E.; Tao, M.; Ong, Y.K.; Chua, E.J. 1999: Phase Ii trial of a paclitaxel and carboplatin combination in Asian patients with metastatic nasopharyngeal carcinoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 10(2): 235-237

Kris, M.G.; Clark, R.A.; Tyson, L.B.; Hahne, W.F.; Pisters, K.M.; Gralla, R.J. 1993: Phase Ii trial of a single intravenous dose of ondansetron in patients receiving cisplatin > or = 100 mg/m2. American Journal of Clinical Oncology 16(1): 77-80

Mikulski, S.M.; Costanzi, J.J.; Vogelzang, N.J.; McCachren, S.; Taub, R.N.; Chun, H.; Mittelman, A.; Panella, T.; Puccio, C.; Fine, R.; Shogen, K. 2002: Phase Ii trial of a single weekly intravenous dose of ranpirnase in patients with unresectable malignant mesothelioma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(1): 274-281

Ellerhorst, J.A.; Tu, S.M.; Amato, R.J.; Finn, L.; Millikan, R.E.; Pagliaro, L.C.; Jackson, A.; Logothetis, C.J. 1997: Phase Ii trial of alternating weekly chemohormonal therapy for patients with androgen-independent prostate cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 3(12 Part 1): 2371-2376

Louvet, C.; André, T.; Hammel, P.; Selle, F.; Landi, B.; Cattan, S.; Fonck, M.; Flesch, M.; Colin, P.; Balosso, J.; Ruszniewski, P.; de Gramont, A. 2001: Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM). Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(5): 675-679

Stathopoulos, G.P.; Rigatos, S.K.; Pergantas, N.; Tsavdarides, D.; Athanasiadis, I.; Malamos, N.A.; Stathopoulos, J.G. 2002: Phase Ii trial of biweekly administration of vinorelbine and gemcitabine in pretreated advanced breast cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(1): 37-41

Motzer, R.J.; Rakhit, A.; Thompson, J.; Gurney, H.; Selby, P.; Figlin, R.; Negrier, S.; Ernst, S.; Siebels, M.; Ginsberg, M.; Rittweger, K.; Hooftman, L. 2002: Phase Ii trial of branched peginterferon-alpha 2a (40 kDa) for patients with advanced renal cell carcinoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(11): 1799-1805

Varterasian, M.L.; Mohammad, R.M.; Shurafa, M.S.; Hulburd, K.; Pemberton, P.A.; Rodriguez, D.H.; Spadoni, V.; Eilender, D.S.; Murgo, A.; Wall, N.; Dan, M.; Al-Katib, A.M. 2000: Phase Ii trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(3): 825-828

Quinn, J.A.; Pluda, J.; Dolan, M.E.; Delaney, S.; Kaplan, R.; Rich, J.N.; Friedman, A.H.; Reardon, D.A.; Sampson, J.H.; Colvin, O.M.; Haglund, M.M.; Pegg, A.E.; Moschel, R.C.; McLendon, R.E.; Provenzale, J.M.; Gururangan, S.; Tourt-Uhlig, S.; Herndon, J.E.; Bigner, D.D.; Friedman, H.S. 2002: Phase Ii trial of carmustine plus O(6)-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(9): 2277-2283

Wierzbicki, R.; Ezzat, A.; Abdel-Warith, A.; Ayoub, A.; Kagevi, I.; Fadda, M.; Sieck, J.; Abdulkareem, M.; Amin, T.; Yazigi, A. 1994: Phase Ii trial of chronic daily VP-16 administration in unresectable hepatocellular carcinoma (HCC). Annals of Oncology: Official Journal of the European Society for Medical Oncology 5(5): 466-467

Cure, H.; Chevalier, V.; Pezet, D.; Bousquet, J.; Focan, C.; Levi, F.; Garufi, C.; Chipponi, J.; Chollet, P. 2000: Phase Ii trial of chronomodulated infusion of 5-fluorouracil and folinic acid in metastatic colorectal cancer. Anticancer Research 20(6c): 4649-4653

Curé, H.; Chevalier, V.; Adenis, A.; Tubiana-Mathieu, N.; Niezgodzki, G.; Kwiatkowski, F.; Pezet, D.; Perpoint, B.; Coudert, B.; Focan, C.; Lévi, F.; Chipponi, J.; Chollet, P. 2002: Phase Ii trial of chronomodulated infusion of high-dose fluorouracil and l-folinic acid in previously untreated patients with metastatic colorectal cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(5): 1175-1181

Hitt, R.; Castellano, D.; Hidalgo, M.; García-Carbonero, R.; Peña, M.; Brandariz, A.; Millán, J.M.; Alvarez Vincent, J.J.; Cortés-Funes, H. 1998: Phase Ii trial of cisplatin and gemcitabine in advanced squamous-cell carcinoma of the head and neck. Annals of Oncology: Official Journal of the European Society for Medical Oncology 9(12): 1347-1349

Patt, Y.Z.; Hassan, M.M.; Lozano, R.D.; Waugh, K.A.; Hoque, A.M.; Frome, A.I.; Lahoti, S.; Ellis, L.; Vauthey, J.N.; Curley, S.A.; Schnirer, I.I.; Raijman, I. 2001: Phase Ii trial of cisplatin, interferon alpha-2b, doxorubicin, and 5-fluorouracil for biliary tract cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 7(11): 3375-3380

Viñolas, N.; Graus, F.; Mellado, B.; Caralt, L.; Estapé, J. 1997: Phase Ii trial of cisplatinum and etoposide in brain metastases of solid tumors. Journal of Neuro-Oncology 35(2): 145-148

Nakanishi, Y.; Kawarada, Y.; Hirose, N.; Ninomiya, K.; Miyazaki, M.; Miyazaki, N.; Kurita, Y.; Kanegae, H.; Ohgushi, O.; Ogata, K.; Yamazaki, H.; Inutsuka, S.; Hara, N. 1998: Phase Ii trial of combination chemotherapy with cisplatin, carboplatin and etoposide in stage IIIB and IV small-cell lung cancer. Fukuoka Lung Cancer Study Group. Cancer ChemoTherapy and Pharmacology 41(6): 453-456

Eckel, F.; Lersch, C.; Lippl, F.; Assmann, G.; Schulte-Frohlinde, E. 2000: Phase Ii trial of cyclophosphamide, leucovorin, 5-fluorouracil 24-hour infusion and tamoxifen in pancreatic cancer. Journal of Experimental and Clinical Cancer Research: Cr 19(3): 295-300

Roche, H.; Cure, H.; Adenis, A.; Fargeot, P.; Terret, C.; Lentz, M.A.; Madelmont, J.C.; Fumoleau, P.; Hanausk, A.; Chollet, P. 2000: Phase Ii trial of cystemustine, a new nitrosourea, as treatment of high-grade brain tumors in adults. Journal of Neuro-Oncology 49(2): 141-145

Ramanathan, R.K.; Cnaan, A.; Hahn, R.G.; Carbone, P.P.; Haller, D.G. 2001: Phase Ii trial of dacarbazine (DTIC) in advanced pancreatic islet cell carcinoma. Study of the Eastern Cooperative Oncology Group-E6282. Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(8): 1139-1143

Hendren, S.K.; Hahn, S.M.; Spitz, F.R.; Bauer, T.W.; Rubin, S.C.; Zhu, T.; Glatstein, E.; Fraker, D.L. 2001: Phase Ii trial of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Annals of Surgical Oncology 8(1): 65-71

Pazdur, R.; Lassere, Y.; Soh, L.T.; Ajani, J.A.; Bready, B.; Soo, E.; Sugarman, S.; Patt, Y.; Abbruzzese, J.L.; Levin, B. 1994: Phase Ii trial of docetaxel (Taxotere) in metastatic colorectal carcinoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 5(5): 468-470

Francis, P.A.; Rigas, J.R.; Kris, M.G.; Pisters, K.M.; Orazem, J.P.; Woolley, K.J.; Heelan, R.T. 1994: Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 12(6): 1232-1237

Smith, R.E.; Anderson, S.J.; Brown, A.; Scholnik, A.P.; Desai, A.M.; Kardinal, C.G.; Lembersky, B.C.; Mamounas, E.P. 2002: Phase Ii trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast cancer: results from NSABP trial BP-58. Clinical Breast Cancer 3(5): 333-340

Buesa, J.M.; López-Pousa, A.; Martín, J.; Antón, A.; García del Muro, J.; Bellmunt, J.; Arranz, F.; Valentí, V.; Escudero, P.; Menéndez, D.; Casado, A.; Poveda, A. 1998: Phase Ii trial of first-line high-dose ifosfamide in advanced soft tissue sarcomas of the adult: a study of the Spanish Group for Research on Sarcomas (GEIS). Annals of Oncology: Official Journal of the European Society for Medical Oncology 9(8): 871-876

Foss, F.M.; Ihde, D.C.; Linnoila, I.R.; Fischmann, A.B.; Schechter, G.P.; Cotelingam, J.D.; Steinberg, S.M.; Ghosh, B.C.; Stocker, J.L.; Bastian, A. 1994: Phase II trial of fludarabine phosphate and interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 12(10): 2051-2059

Feliu, J.; López Alvarez, M.P.; Jaraiz, M.A.; Constenla, M.; Vicent, J.M.; Belón, J.; López Gómez, L.; de Castro, J.; Dorta, J.; González Barón, M. 2000: Phase Ii trial of gemcitabine and UFT modulated by leucovorin in patients with advanced pancreatic carcinoma. the ONCOPAZ Cooperative Group. Cancer 89(8): 1706-1713

Sandler, A.B.; Kindler, H.L.; Einhorn, L.H.; Mitchell, E.; Masters, G.; Kraut, M.; Nicol, S.; Raghavan, D. 2000: Phase Ii trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(9): 1161-1164

O'Shaughnessy, J.; Vukelja, S.J.; Marsland, T.; Kimmel, G.; Ratnam, S.; Pippen, J. 2002: Phase Ii trial of gemcitabine plus trastuzumab in metastatic breast cancer patients previously treated with chemotherapy: preliminary results. Clinical Breast Cancer 3(Suppl 1): 17-20

Sánchez-Rovira, P.; Jaén, A.; González, E.; Porras, I.; Dueñas, M.R.; Medina, B.; Mohedano, N.; Fernández, M.; Martos, M.; Lozano, A. 2000: Phase Ii trial of gemcitabine/doxorubicin/paclitaxel administered every other week in patients with metastatic breast cancer. Clinical Breast Cancer 1(3): 226-232

Nieto, Y.; Cagnoni, P.J.; Shpall, E.J.; Matthes, S.; Barón, A.; Jones, R.B.; Bearman, S.I. 1999: Phase Ii trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic disease. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 5(7): 1731-1737

Shapiro, C.L.; Ervin, T.; Welles, L.; Azarnia, N.; Keating, J.; Hayes, D.F. 1999: Phase II trial of high-dose liposome-encapsulated doxorubicin with granulocyte colony-stimulating factor in metastatic breast cancer. TLC D-99 Study Group. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 17(5): 1435-1441

Goedhals, L.; Vorobiof, D.A.; Bezwoda, W.; Van Merwe, A.; Jordaan, J.P.; Barnardt, P.; Smith, B.L. 1999: Phase Ii trial of I.v. vinorelbine and cisplatin in inoperable locally advanced or disseminated non-small-cell lung cancer: the South African experience. Current Medical Research and Opinion 15(3): 185-192

Schilder, R.J.; Goldberg, M.; Millenson, M.M.; Movsas, B.; Rogatko, A.; Rogers, B.; Langer, C.J. 2000: Phase II trial of induction high-dose chemotherapy followed by surgical resection and radiation therapy for patients with marginally resectable non-small cell carcinoma of the lung. Lung Cancer 27(1): 37-45

Janik, J.E.; Miller, L.L.; Longo, D.L.; Powers, G.C.; Urba, W.J.; Kopp, W.C.; Gause, B.L.; Curti, B.D.; Fenton, R.G.; Oppenheim, J.J.; Conlon, K.C.; Holmlund, J.T.; Sznol, M.; Sharfman, W.H.; Steis, R.G.; Creekmore, S.P.; Alvord, W.G.; Beauchamp, A.E.; Smith, J.W. 1996: Phase Ii trial of interleukin 1 alpha and indomethacin in treatment of metastatic melanoma. Journal of the National Cancer Institute 88(1): 44-49

Dutcher, J.P.; Logan, T.; Gordon, M.; Sosman, J.; Weiss, G.; Margolin, K.; Plasse, T.; Mier, J.; Lotze, M.; Clark, J.; Atkins, M. 2000: Phase Ii trial of interleukin 2, interferon alpha, and 5-fluorouracil in metastatic renal cell cancer: a cytokine working group study. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(9): 3442-3450

Guastalla, J.P.; Lhomme, C.; Kerbrat, P.; Mayer, F.; Namer, M.; Goupil, P.; Charrot, P.; Heron, J.F.; Chazard, M.; Richard, I. 1994: Phase II trial of intraperitoneal carboplatin in ovarian carcinoma patients with macroscopic residual disease at second-look laparotomy. A multicentre study of the French Fédération Nationale des Centres de Lutte Contre le Cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 5(2): 127-132

Morgan, R.J.; Braly, P.; Cecchi, G.; Leong, L.; Shibata, S.; Margolin, K.; Somlo, G.; McNamara, M.; Longmate, J.; Schinke, S.; Raschko, J.; Nagasawa, S.; Kogut, N.; Parker, P.; Stein, A.; Cho, J.; Smith, E.; Coluzzi, P.; Najera, L.; Johnson, D.; Womack, E.; Doroshow, J.H. 1999: Phase Ii trial of intraperitoneal cisplatin with intravenous doxorubicin and cyclophosphamide in previously untreated patients with advanced ovarian cancer-long-term follow-up. Gynecologic Oncology 75(3): 419-426

Patt, Y.Z.; Jones, D.V.; Hoque, A.; Lozano, R.; Markowitz, A.; Raijman, I.; Lynch, P.; Charnsangavej, C. 1996: Phase II trial of intravenous flourouracil and subcutaneous interferon alfa-2b for biliary tract cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 14(8): 2311-2315

Bodurka, D.C.; Levenback, C.; Wolf, J.K.; Gano, J.; Wharton, J.Taylor.; Kavanagh, J.J.; Gershenson, D.M. 2003: Phase II trial of irinotecan in patients with metastatic epithelial ovarian cancer or peritoneal cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21(2): 291-297

Murad, A..M..; Oliveira, M..; Saldanha, T..M.. 1994: Phase Ii trial of isotretinoin and interferon alpha-2a in the treatment of advanced recurrent cervical carcinoma. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 4(6): 414-418

Steele, J.P.; O'Doherty, C.A.; Shamash, J.; Evans, M.T.; Gower, N.H.; Tischkowitz, M.D.; Rudd, R.M. 2001: Phase Ii trial of liposomal daunorubicin in malignant pleural mesothelioma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(4): 497-499

Chidiac, T.; Budd, G.T.; Pelley, R.; Sandstrom, K.; McLain, D.; Elson, P.; Crownover, R.; Marks, K.; Muschler, G.; Joyce, M.; Zehr, R.; Bukowski, R. 2000: Phase Ii trial of liposomal doxorubicin (Doxil) in advanced soft tissue sarcomas. Investigational new Drugs 18(3): 253-259

Eckel, F.; Lersch, C.; Assmann, G.; Schulte-Frohlinde, E. 2000: Phase Ii trial of low-dose cyclophosphamide, leucovorin, high-dose 5-fluorouracil 24-hour continuous infusion and tamoxifen in advanced biliary tract cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 11(6): 762-763

Malik, U.R.; Dutcher, J.P.; Caliendo, G.; Lasala, P.; Mitnick, R.; Wiernik, P.H. 1997: Phase Ii trial of merbarone in patients with malignant brain tumors. Medical Oncology 14(3-4): 159-162

Taal, B.G.; Audisio, R.A.; Bleiberg, H.; Blijham, G.H.; Neijt, J.P.; Veenhof, C.H.; Duez, N.; Sahmoud, T. 1993: Phase Ii trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group Study. Annals of Oncology: Official Journal of the European Society for Medical Oncology 4(7): 607-609

Reardon, D.A.; Akabani, G.; Coleman, R.Edward.; Friedman, A.H.; Friedman, H.S.; Herndon, J.E.; Cokgor, I.; McLendon, R.E.; Pegram, C.N.; Provenzale, J.M.; Quinn, J.A.; Rich, J.N.; Regalado, L.V.; Sampson, J.H.; Shafman, T.D.; Wikstrand, C.J.; Wong, T.Z.; Zhao, X-Guang.; Zalutsky, M.R.; Bigner, D.D. 2002: Phase II trial of murine (131)I-labeled antitenascin monoclonal antibody 81C6 administered into surgically created resection cavities of patients with newly diagnosed malignant gliomas. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(5): 1389-1397

Alonso, V.; Santader, C.; Florian, J.; Alonso, M.; Isla, M.D.; Escudero, P.; Saenz, A.; Tres, A. 1996: Phase Ii trial of oral tegafur and folinic acid with mitoxantrone as first-line regimen in patients with metastatic breast cancer. Tumori 82(1): 61-64

Degardin, M.; Cappelaere, P.; Krakowski, I.; Fargeot, P.; Cupissol, D.; Brienza, S. 1996: Phase Ii trial of oxaliplatin (L-OHP) in advanced, recurrent and/or metastatic squamous cell carcinoma of the head and neck. European Journal of Cancer. Part B Oral Oncology 32b (4): 278-279

Bécouarn, Y.; Ychou, M.; Ducreux, M.; Borel, C.; Bertheault-Cvitkovic, F.; Seitz, J.F.; Nasca, S.; Nguyen, T.D.; Paillot, B.; Raoul, J.L.; Duffour, J.; Fandi, A.; Dupont-André, G.; Rougier, P. 1998: Phase Ii trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients. Digestive Group of French Federation of Cancer Centers. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(8): 2739-2744

Thomas, P.; Castelnau, O.; Paillotin, D.; Léna, H.; Robinet, G.; Muir, J.F.; Delaval, P.; Gouva, S.; Balmes, P.; Blanchon, F.; Perdu, D.; Poirier, R.; Pommier De Santi, P.; Penot-Ragon, C.; Kleisbauer, J.P. 2001: Phase II trial of paclitaxel and carboplatin in metastatic small-cell lung cancer: a Groupe Français de Pneumo-Cancérologie study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 19(5): 1320-1325

Breathnach, O.S.; Georgiadis, M.S.; Schuler, B.S.; Pizzella, P.; Llorens, V.; Kasturi, V.; Steinberg, S.M.; O'Neil, K.; Takimoto, C.H.; Johnson, B.E. 2000: Phase Ii trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(7): 2670-2676

Yamada, Y.; Shirao, K.; Ohtsu, A.; Boku, N.; Hyodo, I.; Saitoh, H.; Miyata, Y.; Taguchi, T. 2001: Phase Ii trial of paclitaxel by three-hour infusion for advanced gastric cancer with short premedication for prophylaxis against paclitaxel-associated hypersensitivity reactions. Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(8): 1133-1137

Ratanatharathorn, V.; Lorvidhaya, V.; Maoleekoonpairoj, S.; Phromratanapongse, P.; Sirilerttrakul, S.; Kraipiboon, P.; Cheirsilpa, A.; Tangkaratt, S.; Srimuninnimit, V.; Pattaranutaporn, P. 2001: Phase Ii trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. Lung Cancer 31(2-3): 257-265

Skubitz, K.M. 2002: Phase Ii trial of pegylated-liposomal doxorubicin (Doxil) in mesothelioma. Cancer Investigation 20(5-6): 693-699

Skubitz, K.M. 2002: Phase Ii trial of pegylated-liposomal doxorubicin (Doxil) in renal cell cancer. Investigational new Drugs 20(1): 101-104

Clarke, S.J.; Abratt, R.; Goedhals, L.; Boyer, M.J.; Millward, M.J.; Ackland, S.P. 2002: Phase Ii trial of pemetrexed disodium (ALIMTA, LY231514) in chemotherapy-naïve patients with advanced non-small-cell lung cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(5): 737-741

Taylor, S.A.; Benedetti, J.; Schuller, D.; Richman, S.P.; Broun, G.O.; Hantel, A. 1993: Phase Ii trial of piroxantrone in patients with recurrent and metastatic squamous cell carcinoma of the head and neck. a Southwest Oncology Group trial. Investigational new Drugs 11(2-3): 227-229

Kuratsu, J.I.; Arita, N.; Kayama, T.; Kubo, N.; Mori, T.; Sawamura, Y.; Ushio, Y. 2000: Phase Ii trial of pre-irradiation KRN8602 (MX2) in malignant glioma patients. Journal of Neuro-Oncology 48(2): 145-149

Mehta, V.K.; Cho, C.; Ford, J.M.; Jambalos, C.; Poen, J.; Koong, A.; Lin, A.; Bastidas, J.A.; Young, H.; Dunphy, E.P.; Fisher, G. 2003: Phase Ii trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. International Journal of Radiation Oncology Biology Physics 55(1): 132-137

Buckner, J.C.; Gesme, D.; O'Fallon, J.R.; Hammack, J.E.; Stafford, S.; Brown, P.D.; Hawkins, R.; Scheithauer, B.W.; Erickson, B.J.; Levitt, R.; Shaw, E.G.; Jenkins, R. 2003: Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 21(2): 251-255

Berg, S.L.; Blaney, S.M.; Sullivan, J.; Bernstein, M.; Dubowy, R.; Harris, M.B. 2000: Phase Ii trial of pyrazoloacridine in children with solid tumors: a Pediatric Oncology Group phase Ii study. Journal of Pediatric Hematology/Oncology 22(6): 506-509

Bramhall, S.R.; Harrison, J.D.; Burton, A.; Wallace, D.M.; Chan, K.K.; Harrison, G.; White, A.; Fielding, J.W. 1999: Phase Ii trial of radical surgery for locally advanced pelvic neoplasia. British Journal of Surgery 86(6): 805-812

Buckner, J.C.; Burch, P.A.; Cascino, T.L.; O'Fallon, J.R.; Scheithauer, B.W. 1998: Phase Ii trial of recombinant interferon-alpha-2a and eflornithine in patients with recurrent glioma. Journal of Neuro-Oncology 36(1): 65-70

Palmero, D.; Eiguchi, K.; Rendo, P.; Castro Zorrilla, L.; Abbate, E.; González Montaner, L.J. 1999: Phase Ii trial of recombinant interferon-alpha2b in patients with advanced intractable multidrug-resistant pulmonary tuberculosis: long-term follow-up. International Journal of Tuberculosis and Lung Disease: the Official Journal of the International Union Against Tuberculosis and Lung Disease 3(3): 214-218

Redman, B.G.; Hillman, G.G.; Flaherty, L.; Forman, J.; Dezso, B.; Haas, G.P. 1998: Phase Ii trial of sequential radiation and interleukin 2 in the treatment of patients with metastatic renal cell carcinoma. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(2): 283-286

Dillman, R.O.; Soori, G.; Wiemann, M.C.; Schulof, R.; Dobbs, T.W.; Ruben, R.H.; DePriest, C.B.; Church, C. 2000: Phase Ii trial of subcutaneous interleukin-2, subcutaneous interferon-alpha, intravenous combination chemotherapy, and oral tamoxifen in the treatment of metastatic melanoma: final results of cancer biotherapy research group 94-11. Cancer BioTherapy and Radiopharmaceuticals 15(5): 487-494

Patt, Y.Z.; Hassan, M.M.; Lozano, R.D.; Brown, T.D.; Vauthey, J.N.; Curley, S.A.; Ellis, L.M. 2003: Phase Ii trial of systemic continuous fluorouracil and subcutaneous recombinant interferon Alfa-2b for treatment of hepatocellular carcinoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21(3): 421-427

Groves, M.D.; Puduvalli, V.K.; Hess, K.R.; Jaeckle, K.A.; Peterson, P.; Yung, W.K.A.; Levin, V.A. 2002: Phase Ii trial of temozolomide plus the matrix metalloproteinase inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(5): 1383-1388

Motzer, R.J.; Berg, W.; Ginsberg, M.; Russo, P.; Vuky, J.; Yu, R.; Bacik, J.; Mazumdar, M. 2002: Phase Ii trial of thalidomide for patients with advanced renal cell carcinoma. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(1): 302-306

Escudier, B.; Lassau, N.; Couanet, D.; Angevin, E.; Mesrati, F.; Leborgne, S.; Garofano, A.; Leboulaire, C.; Dupouy, N.; Laplanche, A. 2002: Phase Ii trial of thalidomide in renal-cell carcinoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(7): 1029-1035

Judson, I.; Cerny, T.; Epelbaum, R.; Dunlop, D.; Smyth, J.; Schaefer, B.; Roelvink, M.; Kaplan, S.; Hanauske, A. 1997: Phase Ii trial of the oral platinum complex JM216 in non-small-cell lung cancer: an EORTC early clinical studies group investigation. Annals of Oncology: Official Journal of the European Society for Medical Oncology 8(6): 604-606

Muggia, F.M.; Blessing, J.A.; Sorosky, J.; Reid, G.C. 2002: Phase Ii trial of the pegylated liposomal doxorubicin in previously treated metastatic endometrial cancer: a Gynecologic Oncology Group study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(9): 2360-2364

Bedikian, A.Y.; Legha, S.S.; Eton, O.; Buzaid, A.C.; Papadopoulos, N.; Coates, S.; Simmons, T.; Neefe, J.; von Roemeling, R. 1997: Phase Ii trial of tirapazamine combined with cisplatin in chemotherapy of advanced malignant melanoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 8(4): 363-367

Blaney, S.M.; Needle, M.N.; Gillespie, A.; Sato, J.K.; Reaman, G.H.; Berg, S.L.; Adamson, P.C.; Krailo, M.D.; Bleyer, W.A.; Poplack, D.G.; Balis, F.M. 1998: Phase II trial of topotecan administered as 72-hour continuous infusion in children with refractory solid tumors: a collaborative Pediatric Branch, National Cancer Institute, and Children's Cancer Group Study. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(2): 357-360

Penz, M.; Kornek, G.V.; Raderer, M.; Ulrich-Pur, H.; Fiebiger, W.; Lenauer, A.; Depisch, D.; Krauss, G.; Schneeweiss, B.; Scheithauer, W. 2001: Phase Ii trial of two-weekly gemcitabine in patients with advanced biliary tract cancer. Annals of Oncology: Official Journal of the European Society for Medical Oncology 12(2): 183-186

Hügli, A.; Moro, D.; Mermillod, B.; Bolla, M.; Alberto, P.; Bonnefoi, H.; Miralbell, R. 2000: Phase Ii trial of up-front accelerated thoracic radiotherapy combined with chemotherapy and optional up-front prophylactic cranial irradiation in limited small-cell lung cancer. Groupe d'Oncologie Thoracique des Régions Alpines. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 18(8): 1662-1667

Mani, S.; Kugler, J.W.; Sciortino, D.F.; Garcia, J.C.; Ansari, R.H.; Humerickhouse, R.; Michelassi, F.; Posner, M.C.; Shulman, K.L.; Schilsky, R.L.; List, M.; Vokes, E.E.; Benner, S. 1998: Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced pancreatic carcinoma: a University of Chicago phase II consortium study. Annals of oncology: official journal of the European Society for Medical Oncology 9(9): 1035-1037

Conroy, T.; Etienne, P.L.; Adenis, A.; Wagener, D.J.; Paillot, B.; François, E.; Bedenne, L.; Jacob, J.H.; Seitz, J.F.; Bleiberg, H.; Van Pottelsberghe, C.; Van Glabbeke, M.; Delgado, F.M.; Merle, S.; Wils, J. 1996: Phase Ii trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 14(1): 164-170

Choy, H.; Safran, H.; Akerley, W.; Graziano, S.L.; Bogart, J.A.; Cole, B.F. 1998: Phase Ii trial of weekly paclitaxel and concurrent radiation therapy for locally advanced non-small cell lung cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(8): 1931-1936

Vaughn, D.J.; Broome, C.M.; Hussain, M.; Gutheil, J.C.; Markowitz, A.B. 2002: Phase Ii trial of weekly paclitaxel in patients with previously treated advanced urothelial cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(4): 937-940

Markman, M.; Hall, J.; Spitz, D.; Weiner, S.; Carson, L.; Van Le, L.; Baker, M. 2002: Phase Ii trial of weekly single-agent paclitaxel in platinum/paclitaxel-refractory ovarian cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(9): 2365-2369

Jahanzeb, M.; Mortimer, J.E.; Yunus, F.; Irwin, D.H.; Speyer, J.; Koletsky, A.J.; Klein, P.; Sabir, T.; Kronish, L. 2002: Phase Ii trial of weekly vinorelbine and trastuzumab as first-line therapy in patients with HER2(+) metastatic breast cancer. Oncologist 7(5): 410-417

Knox, S.J.; Goris, M.L.; Tempero, M.; Weiden, P.L.; Gentner, L.; Breitz, H.; Adams, G.P.; Axworthy, D.; Gaffigan, S.; Bryan, K.; Fisher, D.R.; Colcher, D.; Horak, I.D.; Weiner, L.M. 2000: Phase Ii trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(2): 406-414

Markman, M.; DeMarco, L.C.; Birkhofer, M.; Budman, D.; Hakes, T.; Reichman, B.; Rubin, S.; Jones, W.; Barakat, R.; Curtin, J. 1993: Phase Ii trial of zeniplatin (CL 286,558), a new patinum compound, in patients with advanced ovarian cancer previously treated with organoplatinum-based therapy. Journal of Cancer Research and Clinical Oncology 119(4): 234-236

Rebattu, P.; Coudert, B.; Schneider, M.; Ouabdesselam, R.; Lentz, M.; Hanauske, A.; Chevallierdagger, B.; Fumoleau, P.; Chollet, P. 2000: Phase Ii trial with cystemustine (60 mg/m2) in advanced or metastatic pretreated lung carcinoma. Revue de Pneumologie Clinique 56(3): 200-203

Wils, J.A.; Kok, T.; Wagener, D.J.; Francois, E.; Selleslags, J.; Duez, N. 1993: Phase Ii trial with ifosfamide in pancreatic cancer. European Journal of Cancer 29a (2): 290

Richardet, E.; Carranza, L.; Uribe, A.; Tolocka, H.; Cresta, C.; Uribe, E.; Uribe, M. 1995: Phase Ii trial with navelbine + cisplatin + etoposide in the treatment of inoperable non-small cell lung carcinoma. Revista de la Facultad de Ciencias Medicas 53(1): 27-32

Sardi, J.E. 1996: Phase Ii trial with neoadjuvant chemotherapy. Gynecologic Oncology 62(2): 321-322

Shelley, J.H. 1999: Phase Ii trials in drug development. British Journal of Clinical Pharmacology 48(1): 106-107

Kraut, E.H. 2000: Phase Ii trials of pentostatin (Nipent) in hairy cell leukemia. Seminars in Oncology 27(2 Suppl 5: 27-31

Smith, M.A.; Anderson, B. 2001: Phase II window studies: 10 years of experience and counting. Journal of Pediatric Hematology/Oncology 23(6): 334-337

Pantely, G.A.; Joyce, M.; Grauer, S.E.; Giraud, G.D.; Shiota, T.; Sahn, D. 1998: Phase II, placebo-controlled trial of MRX115 (Aerosomes) for left heart and myocardial perfusion imaging. Academic Radiology 5(Suppl 1): S66

Kabbinavar, F.; Hurwitz, H.I.; Fehrenbacher, L.; Meropol, N.J.; Novotny, W.F.; Lieberman, G.; Griffing, S.; Bergsland, E. 2003: Phase II, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 21(1): 60-65

Krown, S.E.; Aeppli, D.; Balfour, H.H. 1999: Phase II, randomized, open-label, community-based trial to compare the safety and activity of combination therapy with recombinant interferon-alpha2b and zidovudine versus zidovudine alone in patients with asymptomatic to mildly symptomatic HIV infection. HIV Protocol C91-253 Study Team. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology: Official Publication of the International Retrovirology Association 20(3): 245-254

Coughlin, C.; Scott, C.; Langer, C.; Coia, L.; Curran, W.; Rubin, P. 2000: Phase II, two-arm RTOG trial (94-11) of bischloroethyl-nitrosourea plus accelerated hyperfractionated radiotherapy (64.0 or 70.4 Gy) based on tumor volume (> 20 or < or = 20 cm(2), respectively) in the treatment of newly-diagnosed radiosurgery-ineligible glioblastoma multiforme patients. International Journal of Radiation Oncology Biology Physics 48(5): 1351-1358

Goorin, A.M.; Harris, M.B.; Bernstein, M.; Ferguson, W.; Devidas, M.; Siegal, G.P.; Gebhardt, M.C.; Schwartz, C.L.; Link, M.; Grier, H.E. 2002: Phase II/IIi trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(2): 426-433

Werner-Wasik, M.; Axelrod, R.S.; Friedland, D.P.; Hauck, W.; Rose, L.J.; Chapman, A.E.; Grubbs, S.; Deshields, M.; Curran, W.J. 2002: Phase II: trial of twice weekly amifostine in patients with non-small cell lung cancer treated with chemoradiotherapy. Seminars in Radiation Oncology 12(1 Suppl 1: 34-39

Halazonetis, D.J. 1999: Morphing and warping: Part Ii. American Journal of Orthodontics and Dentofacial Orthopedics: Official Publication of the American Association of Orthodontists its Constituent Societies and the American Board of Orthodontics 115(6): 706-708

Xu, B.; Zhou, J.; Zhou, A. 1997: Phase IIi clinical studies with ondansetron (Qilu) in the prophylaxis of nausea and vomiting induced by cisplatin. Zhonghua Zhong Liu Za Zhi 19(5): 358-361

Zhou, J.; Xu, B.; Zhou, A. 1997: Phase IIi clinical studies with ondansetron (Qilu) in the prophylaxis of nausea and vomiting induced by non-cisplatin chemotherapy. Zhonghua Zhong Liu Za Zhi 19(6): 460-462

Li, Q.; Feng, F.-y.; Han, J.; Sui, G.-j.; Zhu, Y.-g.; Zhang, Y.; Zhang, Z.-h.; Li, L.; Wang, P.-h.; Zhou, M.-z.; Zhang, Y.-c. 2002: Phase IIi clinical study of a new anticancer drug atofluding. Ai Zheng 21(12): 1350-1353

Poirier, V.C.; Newberry, P.D.; Hecht, S.T.; Nemzek, W.R. 1996: Phase IIi clinical trial comparing iodixanol and iohexol in cerebral angiography. Academic Radiology 3(Suppl 3): S495-S499

Kimura, S.; Shimada, K.; Matsuda, J.; Gohchi, K.; Fukutake, K.; Fukue, H.; Okubo, T.; Ishigatsubo, Y.; Yamada, K.; Koitabashi, Y. 1994: Phase IIi clinical trial of KRN8601 (rhG-CSF) for neutropenia in patients with human immunodeficiency virus infection. Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 68(9): 1093-1104

Luetje, C.M.; Brackman, D.; Balkany, T.J.; Maw, J.; Baker, R.S.; Kelsall, D.; Backous, D.; Miyamoto, R.; Parisier, S.; Arts, A. 2002: Phase IIi clinical trial results with the Vibrant Soundbridge implantable middle ear hearing device: a prospective controlled multicenter study. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 126(2): 97-107

Morere, J.F. 2001: Phase IIi clinical trials concerning non-small-cell lung carcinoma (NSCLC) presented at the ASCO 2001. Revue de Pneumologie Clinique 57(5 Part 2): S37-S41

Zinzani, P.L.; Martelli, M.; Storti, S.; Musso, M.; Cantonetti, M.; Leone, G.; Cajozzo, A.; Papa, G.; Iannitto, E.; Perrotti, A. 1995: Phase IIi comparative trial using CHOP vs CIOP in the treatment of advanced intermediate-grade non-Hodgkin's lymphoma. Leukemia and Lymphoma 19(3-4): 329-335

Mochiki, H.; Yamamoto, O.; Mizumoto, A.; Ito, S. 1995: Phase IIi contraction inhibition and gastric acidification in Pavlov and Heidenhain pouch in dogs. Journal of Smooth Muscle Research 31(6): 498-503

Muggia, F.; Hamilton, A. 2001: Phase IIi data on Caelyx in ovarian cancer. European Journal of Cancer 37(Suppl 9): S15-S18

Zimniak, P.; Awasthi, S.; Awasthi, Y.C. 1993: Phase IIi detoxification system. Trends in Biochemical Sciences 18(5): 164-166

Vore, M. 1994: Phase IIi elimination: another two-edge sword. Environmental Health Perspectives 102(5): 422-423

Loprinzi, C.L.; Sloan, J.A.; Perez, E.A.; Quella, S.K.; Stella, P.J.; Mailliard, J.A.; Halyard, M.Y.; Pruthi, S.; Novotny, P.J.; Rummans, T.A. 2002: Phase IIi evaluation of fluoxetine for treatment of hot flashes. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(6): 1578-1583

Burch, P.A.; Block, M.; Schroeder, G.; Kugler, J.W.; Sargent, D.J.; Braich, T.A.; Mailliard, J.A.; Michalak, J.C.; Hatfield, A.K.; Wright, K.; Kuross, S.A. 2000: Phase IIi evaluation of octreotide versus chemotherapy with 5-fluorouracil or 5-fluorouracil plus leucovorin in advanced exocrine pancreatic cancer: a North Central Cancer Treatment Group study. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(9): 3486-3492

Moyle, G. 2001: Use of HIV protease inhibitors as pharmacoenhancers. Aids Reader 11(2): 87-98; Quiz: 107-108

Fort, D.J.; Stover, E.L.; Bantle, J.A.; Rayburn, J.R.; Hull, M.A.; Finch, R.A.; Burton, D.T.; Turley, S.D.; Dawson, D.A.; Linder, G.; Buchwalter, D.; Dumont, J.N.; Kumsher-King, M.; Gaudet-Hull, A.M. 1998: Phase IIi interlaboratory study of FETAX, Part 2: interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay--Xenopus (FETAX). Drug and Chemical Toxicology 21(1): 1-14

Grayburn, P.A.; Weiss, J.L.; Hack, T.C.; Klodas, E.; Raichlen, J.S.; Vannan, M.A.; Klein, A.L.; Kitzman, D.W.; Chrysant, S.G.; Cohen, J.L.; Abrahamson, D.; Foster, E.; Perez, J.E.; Aurigemma, G.P.; Panza, J.A.; Picard, M.H.; Byrd, B.F.; Segar, D.S.; Jacobson, S.A.; Sahn, D.J.; DeMaria, A.N. 1998: Phase IIi multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms. Journal of the American College of Cardiology 32(1): 230-236

Feurle, G.E.; Pfeiffer, A.; Schmidt, T.; Dominguez-Munoz, E.; Malfertheiner, P.; Hamscher, G. 2001: Phase IIi of the migrating motor complex: associated with endogenous xenin plasma peaks and induced by exogenous xenin. Neurogastroenterology and Motility: the Official Journal of the European Gastrointestinal Motility Society 13(3): 237-246

Rosell, R.; Gatzemeier, U.; Betticher, D.C.; Keppler, U.; Macha, H.N.; Pirker, R.; Berthet, P.; Breau, J.L.; Lianes, P.; Nicholson, M.; Ardizzoni, A.; Chemaissani, A.; Bogaerts, J.; Gallant, G. 2002: Phase III randomised trial comparing paclitaxel/carboplatin with paclitaxel/cisplatin in patients with advanced non-small-cell lung cancer: a cooperative multinational trial. Annals of Oncology: Official Journal of the European Society for Medical Oncology 13(10): 1539-1549

André, M.; Baudoux, E.; Bron, D.; Canon, J.-L.; D'Hondt, V.ér.; Fassotte, M.-F.; D'Hondt, L.; Fillet, G.; Humblet, Y.; Jerusalem, G.; Vermeulen, P.; Symann, M.; Beguin, Y. 2003: Phase IIi randomized study comparing 5 or 10 microg per kg per day of filgrastim for mobilization of peripheral blood progenitor cells with chemotherapy, followed by intensification and autologous transplantation in patients with nonmyeloid malignancies. Transfusion 43(1): 50-57

Levin, V.A.; Uhm, J.H.; Jaeckle, K.A.; Choucair, A.; Flynn, P.J.; Yung WKA; Prados, M.D.; Bruner, J.M.; Chang, S.M.; Kyritsis, A.P.; Gleason, M.J.; Hess, K.R. 2000: Phase IIi randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 6(10): 3878-3884

Sculier, J.P.; Paesmans, M.; Thiriaux, J.; Lecomte, J.; Bureau, G.; Giner, V.; Efremidis, A.; Lafitte, J.J.; Berchier, M.C.; Alexopoulos, C.G.; Zacharias, C.; Mommen, P.; Ninane, V.; Klastersky, J. 1998: Phase IIi randomized trial comparing cisplatin and carboplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer. European Lung Cancer Working Party. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(4): 1388-1396

Scagliotti, G.V.; De Marinis, F.; Rinaldi, M.; Crinò, L.; Gridelli, C.; Ricci, S.; Matano, E.; Boni, C.; Marangolo, M.; Failla, G.; Altavilla, G.; Adamo, V.; Ceribelli, A.; Clerici, M.; Di Costanzo, F.; Frontini, L.; Tonato, M. 2002: Phase IIi randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(21): 4285-4291

Vikram, B. 2001: Phase IIi randomized trial of amifostine as a radioprotector in head and neck cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 19(4): 1233-1234

Pass, H.I.; Temeck, B.K.; Kranda, K.; Thomas, G.; Russo, A.; Smith, P.; Friauf, W.; Steinberg, S.M. 1997: Phase IIi randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Annals of Surgical Oncology 4(8): 628-633

Anonymous 1998: Phase III results of second-generation HIV protease inhibitor reported. Oncology 12(11): 1616

Anonymous 1998: Phase III results presented on amprenavir triple combination. AIDS patient care and STDs 12(12): 941-942

Anonymous 1995: Phase III saquinavir clinical trials. Journal of the International Association of Physicians in Aids Care 1(5): 33

Johnstone, D.W.; Byhardt, R.W.; Ettinger, D.; Scott, C.B. 2002: Phase III study comparing chemotherapy and radiotherapy with preoperative chemotherapy and surgical resection in patients with non-small-cell lung cancer with spread to mediastinal lymph nodes (N2); final report of RTOG 89-01. Radiation Therapy Oncology Group. International Journal of Radiation Oncology Biology Physics 54(2): 365-369

Takada, M.; Fukuoka, M.; Kawahara, M.; Sugiura, T.; Yokoyama, A.; Yokota, S.; Nishiwaki, Y.; Watanabe, K.; Noda, K.; Tamura, T.; Fukuda, H.; Saijo, N. 2002: Phase IIi study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(14): 3054-3060

Renard, A.; Noël, G.; Mazeron, J.J. 2000: Phase IIi study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesin and cisplatin in unresectable stage IIi non small-cell lung cancer. Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie Oncologique 4(4): 317-318

Berlin, J.D.; Catalano, P.; Thomas, J.P.; Kugler, J.W.; Haller, D.G.; Benson, A.B. 2002: Phase IIi study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(15): 3270-3275

Shimizu, Y. 2002: Phase IIi study of gynecologic cancer in Japan. Gan to Kagaku Ryoho. Cancer and ChemoTherapy 29(9): 1540-1548

Furuse, K.; Fukuoka, M.; Nishiwaki, Y.; Kurita, Y.; Watanabe, K.; Noda, K.; Ariyoshi, Y.; Tamura, T.; Saijo, N. 1998: Phase IIi study of intensive weekly chemotherapy with recombinant human granulocyte colony-stimulating factor versus standard chemotherapy in extensive-disease small-cell lung cancer. the Japan Clinical Oncology Group. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(6): 2126-2132

Emami, B.; Scott, C.; Perez, C.A.; Asbell, S.; Swift, P.; Grigsby, P.; Montesano, A.; Rubin, P.; Curran, W.; Delrowe, J.; Arastu, H.; Fu, K.; Moros, E. 1996: Phase IIi study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors. a prospectively controlled randomized study by the Radiation Therapy Group. International Journal of Radiation Oncology Biology Physics 34(5): 1097-1104

Socinski, M.A.; Schell, M.J.; Peterman, A.; Bakri, K.; Yates, S.; Gitten, R.; Unger, P.; Lee, J.; Lee, J.-H.; Tynan, M.; Moore, M.; Kies, M.S. 2002: Phase IIi trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(5): 1335-1343

Nabholtz, J-Marc.; Cantin, J.; Chang, J.; Guevin, R.; Patel, R.; Tkaczuk, K.; Vodvarka, P.; Lindsay, M-Ann.; Reese, D.; Riva, A.; Mackey, J. 2002: Phase III trial comparing granulocyte colony-stimulating factor to leridistim in the prevention of neutropenic complications in breast cancer patients treated with docetaxel/doxorubicin/cyclophosphamide: results of the BCIRG 004 trial. Clinical Breast Cancer 3(4): 268-275

Pearcey, R.; Brundage, M.; Drouin, P.; Jeffrey, J.; Johnston, D.; Lukka, H.; MacLean, G.; Souhami, L.; Stuart, G.; Tu, D. 2002: Phase IIi trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(4): 966-972

Anonymous 1999: Phase III trial of IL-2. AIDS patient care and STDs 13(12): 753-754

Gibson, A.D. 2002: Phase IIi trial of a humanized anti-CD33 antibody (HuM195) in patients with relapsed or refractory acute myeloid leukemia. Clinical Lymphoma 3(1): 18-19

Matveeva, A.G.; Nekrasov, V.M.; Maryasov, A.G. 2017: Analytical solution of the PELDOR inverse problem using the integral Mellin transform. Physical Chemistry Chemical Physics: Pccp 19(48): 32381-32388

Falkson, C.I.; Ibrahim, J.; Kirkwood, J.M.; Coates, A.S.; Atkins, M.B.; Blum, R.H. 1998: Phase III trial of dacarbazine versus dacarbazine with interferon alpha-2b versus dacarbazine with tamoxifen versus dacarbazine with interferon alpha-2b and tamoxifen in patients with metastatic malignant melanoma: an Eastern Cooperative Oncology Group study. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(5): 1743-1751

Siefker-Radtke, A.O.; Millikan, R.E.; Tu, S.-M.; Moore, D.F.; Smith, T.L.; Williams, D.; Logothetis, C.J. 2002: Phase IIi trial of fluorouracil, interferon alpha-2b, and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic or unresectable urothelial cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 20(5): 1361-1367

Schrijvers, D.; Johnson, J.; Jiminez, U.; Gore, M.; Kosmidis, P.; Szpirglas, H.; Robbins, K.; Oliveira, J.; Lewensohn, R.; Schüller, J.; Riviere, A.; Arvay, C.; Langecker, P.; Jacob, H.; Cvitkovic, E.; Vokes, E. 1998: Phase IIi trial of modulation of cisplatin/fluorouracil chemotherapy by interferon alfa-2b in patients with recurrent or metastatic head and neck cancer. Head and Neck Interferon Cooperative Study Group. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 16(3): 1054-1059

Clayman, R.V. 1999: Characterization of urinary calculi: in vitro study of "twinkling artifact" revealed by color-flow sonography. Journal of Urology 162(2): 632

MacVicar, D.; Jacobsen, T.F.; Guy, R.; Husband, J.E. 1993: Phase III trial of oral magnetic particles in MRI of abdomen and pelvis. Clinical Radiology 47(3): 183-188

Pierce, K.; Courchesne, E. 2001: Evidence for a cerebellar role in reduced exploration and stereotyped behavior in autism. Biological Psychiatry 49(8): 655-664

Richieri, S. 1995: Phase IIi trials for whole inactivated HIV. Lancet 345(8953): 861

Gams, R. 1997: Phase IIi trials of toremifene vs tamoxifen. Oncology 11(5 Suppl 4: 23-28

Bodsworth, N.J.; Bloch, M.; Bower, M.; Donnell, D.; Yocum, R. 2001: Phase IIi vehicle-controlled, multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma. American Journal of Clinical Dermatology 2(2): 77-87

Dunn, B.K.; Kramer, B.S.; Ford, L.G. 1998: Phase III, large-scale chemoprevention trials. Approach to chemoprevention clinical trials and phase III clinical trial of tamoxifen as a chemopreventive for breast cancer--the US National Cancer Institute experience. Hematology/Oncology Clinics of North America 12(5): 1019-36 Vii

Greco, A.; Parker, J.R.; Ratcliffe, C.G.; Kirchin, M.A.; McNamara, M.T. 2001: Phase III, randomized, double-blind, cross-over comparison of gadoteridol and gadopentetate dimeglumine in magnetic resonance imaging of patients with intracranial lesions. Australasian Radiology 45(4): 457-463

Arimori, S.; Terada, H.; Hayami, K.; Aoyagi, Y.; Motomura, S.; Fukawa, H.; Akatsuka, N.; Shimizu, S.; Kodama, F.; Chiba, S. 1993: Phase IV group study of natural human interferon alpha (HLBI) on chronic myelogeneous leukaemia. BioTherapy 6(2): 149-153

Segura, A.; Villalbí, J.R. 1996: Phase IV of epidemiological studies: conceptual and methodological criticisms. Medicina Clinica 106(16): 637-639

Li, J.T.; Yoshida, M.; Nakatsuka, K. 1995: Phase IV study (postmarketing surveillance) of Tarivid (ofloxacin) in China. Drugs 49(Suppl 2): 474-476

Anonymous 1996: Phase Ia trial of a polynucleotide anti-tumor immunization to human carcinoembryonic antigen in patients with metastatic colorectal cancer. Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, Alabama. Human Gene Therapy 7(6): 755-772

Brooks, D.; Taylor, C.; Dos Santos, B.; Linden, H.; Houghton, A.; Hecht, T.T.; Kornfeld, S.; Taetle, R. 1995: Phase Ia trial of murine immunoglobulin a antitransferrin receptor antibody 42/6. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 1(11): 1259-1265

Grant, S.; Roberts, J.; Poplin, E.; Tombes, M.B.; Kyle, B.; Welch, D.; Carr, M.; Bear, H.D. 1998: Phase Ib trial of bryostatin 1 in patients with refractory malignancies. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 4(3): 611-618

Cui; Zhang; Chen 2000: Phase Lag and Coherence Function of X-Ray Emission from Black Hole Candidate XTE J1550-564. Astrophysical Journal 531(1): L45-L48

Friedrich; Trost 1996: Phase Loss in WKB Waves Due to Reflection by a Potential. Physical Review Letters 76(26): 4869-4873

Lacasta; Sancho; Sagués 1995: Phase Separation Dynamics under Stirring. Physical Review Letters 75(9): 1791-1794

Müller-Buschbaum; O'Neill; Affrossman; Stamm 1998: Phase Separation and Dewetting of Weakly Incompatible Polymer Blend Films. Macromolecules 31(15): 5003-5009

Cho; Chou; Johnston 1993: Phase Separation and Finite Size Scaling in La2-xSrxCuO4+ delta. Physical Review Letters 70(2): 222-225

Kumar; Weinhold 1996: Phase Separation in Nearly Symmetric Polymer Mixtures. Physical Review Letters 77(8): 1512-1515

Van Dongen PG 1995: Phase Separation in the Extended Hubbard Model at Weak Coupling. Physical Review Letters 74(1): 182-185

Tuinier; de Kruif CG 1999: Phase Separation, Creaming, and Network Formation of Oil-in-Water Emulsions Induced by an Exocellular Polysaccharide. Journal of Colloid and Interface Science 218(1): 201-210

Sheng; Chen; Weng 1996: Phase String Effect in a Doped Antiferromagnet. Physical Review Letters 77(25): 5102-5105

So; Park; Kim; Moon 1997: Phase Transformation Behavior at Low Temperature in Hydrothermal Treatment of Stable and Unstable Titania Sol. Journal of Colloid and Interface Science 191(2): 398-406

Fainerman; Miller 2000: Phase Transition Processes in Surfactant Adsorption Layers. Journal of Colloid and Interface Science 232(2): 254-259

Ueda; Yoshikawa 1996: Phase Transition and Phase Segregation in a Single Double-Stranded DNA Molecule. Physical Review Letters 77(10): 2133-2136

Robinson; Drysdale 1996: Phase Transition between Coherent and Incoherent Three-Wave Interactions. Physical Review Letters 77(13): 2698-2701

Collins; Dhathathreyan; Ramasami 1998: Phase Transition in Langmuir Films of Octadecylmalonic Acid. Journal of Colloid and Interface Science 203(2): 249-253

Hill; Zia; Schmittmann 1996: Phase Transitions in Driven Bilayer Systems: a Monte Carlo Study. Physical Review Letters 77(3): 514-517

Heiselberg; Hjorth-Jensen 1999: Phase Transitions in Neutron Stars and Maximum Masses. Astrophysical Journal 525(1): L45-L48

Martín-Delgado; Shankar; Sierra 1996: Phase Transitions in Staggered Spin Ladders. Physical Review Letters 77(16): 3443-3446

Martin, S.T.. 2000: Phase Transitions of Aqueous Atmospheric Particles. Chemical Reviews 100(9): 3403-3454

Cao, P.; Luo, J.; Zhu, T. 1998: Phase aberration correction for ultrasound imaging. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 15(1): 84-87

Ries, L.L.; Smith, S.W. 1995: Phase aberration correction in two dimensions using a deformable array transducer. Ultrasonic Imaging 17(3): 227-247

Debbins, J.P.; Felmlee, J.P.; Riederer, S.J. 1997: Phase alignment of multiple surface coil data for reduced bandwidth and reconstruction requirements. Magnetic Resonance in Medicine 38(6): 1003-1011

Van Isacker P; Frank; Dukelsky 1985: Phase ambiguities in the O(6) limit of the interacting boson model. Physical Review. C Nuclear Physics 31(2): 671-673

Turnipseed, D.L. 2000: Phase analysis of burnout and other psychological phenomena. Psychological Reports 87(1): 341-345

Smith 1985: Phase analysis of image states and surface states associated with nearly-free-electron band gaps. Physical Review. B Condensed Matter 32(6): 3549-3555

Ginter, J.; Blinowska, K.J.; Kamiński, M.; Durka, P.J. 2001: Phase and amplitude analysis in time-frequency space--application to voluntary finger movement. Journal of Neuroscience Methods 110(1-2): 113-124

Ciuchi; San Miguel M; Abraham; de Pasquale F 1991: Phase and amplitude correlations induced by the switch-on chirp of a detuned laser. Physical Review. A Atomic Molecular and Optical Physics 44(11): 7657-7668

Zeghlache; Mandel; Abraham; Weiss 1988: Phase and amplitude dynamics in the laser Lorenz model. Physical Review. A General Physics 38(6): 3128-3131

Bestehorn 1993: Phase and amplitude instabilities for Bénard-Marangoni convection in fluid layers with large aspect ratio. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 48(5): 3622-3634

Wu; Griffin 1995: Phase and amplitude modes in a superconductor with interlayer pair tunneling. Physical Review Letters 74(1): 158-161

Launois; Moussa; Lemée-Cailleau; Cailleau 1989: Phase and amplitude modes of the n=4 incommensurate phase Ii of biphenyl: Neutron scattering experiments and theoretical results. Physical Review. B Condensed Matter 40(7): 5042-5055

Nicolás, J.; Campos, J.; Yzuel, M.ía.J. 2002: Phase and amplitude modulation of elliptic polarization states by nonabsorbing anisotropic elements: application to liquid-crystal devices. Journal of the Optical Society of America. a Optics Image Science and Vision 19(5): 1013-1020

Widmann; Sugai; Yamazaki; Hayano; Iwasaki; Nakamura; Tamura; Ito; Kawachi; Nishida; Higemoto; Ito; Morita; Hartmann; Daniel; von Egidy T; Schmid; Hoffmann; Eades 1995: Phase and density dependence of the delayed annihilation of metastable antiprotonic helium atoms in gas, liquid, and solid helium. Physical Review. A Atomic Molecular and Optical Physics 51(4): 2870-2880

Kesar, A.; Jerby, E. 2002: Phase and gain measurements in a distributed-loss cyclotron-resonance maser amplifier. Physical Review. E Statistical Nonlinear and Soft Matter Physics 65(3 Pt 2b): 036503

Padilla, F.; Laugier, P. 2000: Phase and group velocities of fast and slow compressional waves in trabecular bone. Journal of the Acoustical Society of America 108(4): 1949-1952

Braunstein; Caves 1990: Phase and homodyne statistics of generalized squeezed states. Physical Review. A Atomic Molecular and Optical Physics 42(7): 4115-4119

Blank; Shapiro 1995: Phase and intensity control of integral and differential above-threshold ionization rates. Physical Review. A Atomic Molecular and Optical Physics 52(5): 4278-4281

Huang 1994: Phase and photon-number squeezings in a many-cascade two-photon correlated-spontaneous-emission laser. Physical Review. A Atomic Molecular and Optical Physics 49(5): 4247-4250

Conti, M. 1999: Phase and solute fields across the solid-liquid interface of a binary alloy. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 60(2 Part B): 1913-1920

Meng; Chai; Zhang 1993: Phase and squeezing properties of two copropagating fields in a Kerr medium. Physical Review. A Atomic Molecular and Optical Physics 48(4): 3219-3224

Dzakula 2000: Phase angle measurement from peak areas (PAMPAS). Journal of Magnetic Resonance 146(1): 20-32

Chumlea, W.C.; Guo, S.S.; Siervogel, R.M. 1998: Phase angle spectrum analysis and body water. Applied Radiation and Isotopes: Including Data Instrumentation and Methods for use in Agriculture Industry and Medicine 49(5-6): 489-491

Ning; Haken 1991: Phase anholonomy in dissipative optical systems with periodic oscillations. Physical Review. A Atomic Molecular and Optical Physics 43(11): 6410-6413

Littlejohn 1988: Phase anholonomy in the classical adiabatic motion of charged particles. Physical Review. A General Physics 38(12): 6034-6045

Brasunas, J.C. 2002: Phase anomalies in fourier-transform spectrometers: an absorbing beam splitter is neither sufficient nor necessary. Applied Optics 41(13): 2481-2487

Fried; Gabellini 1995: Phase averaging and generalized eikonal representations. Physical Review. D Particles and Fields 51(2): 890-905

Jamee; Pitsi; Li; Nguyen; Sigaud; Thoen 2000: Phase behavior and blue-phase-III-isotropic critical point in (R)-(S) mixtures of a chiral liquid crystal with a direct twist-grain-boundary to blue-phase transition. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 62(3 Part B): 3687-3693

Bates, M.A. 2002: Phase behavior and free interfaces of a lattice-gas nematic-liquid-crystal model. Physical Review. E Statistical Nonlinear and Soft Matter Physics 65(4 Part 1): 041706

Schwarz; Safran 2000: Phase behavior and material properties of hollow nanoparticles. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 62(5 Pt B): 6957-6967

Wilding, N.B.; Magee, J.E. 2002: Phase behavior and thermodynamic anomalies of core-softened fluids. Physical Review. E Statistical Nonlinear and Soft Matter Physics 66(3 Part 1): 031509

Knoll, A.; Horvat, A.; Lyakhova, K.S.; Krausch, G.; Sevink, G.J.A.; Zvelindovsky, A.V.; Magerle, R. 2002: Phase behavior in thin films of cylinder-forming block copolymers. Physical Review Letters 89(3): 035501

Van Der Kooij FM; Vogel; Lekkerkerker 2000: Phase behavior of a mixture of platelike colloids and nonadsorbing polymer. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 62(4 Part B): 5397-5402

Ilett; Orrock; Poon; Pusey 1995: Phase behavior of a model colloid-polymer mixture. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 51(2): 1344-1352

Sear 2000: Phase behavior of a model of colloidal particles with a fluctuating internal state. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 62(2 Pt B): 2501-2509

Klapp, S.; Forstmann, F. 1999: Phase behavior of aligned dipolar hard spheres: integral equations and density functional results. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 60(3): 3183-3198

Lu, Q.; Zografi, G. 1998: Phase behavior of binary and ternary amorphous mixtures containing indomethacin, citric acid, and PVP. Pharmaceutical Research 15(8): 1202-1206

Velasco, E.; Navascués, G.; Mederos, L. 1999: Phase behavior of binary hard-sphere mixtures from perturbation theory. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 60(3): 3158-3164

Brunner, M.; Bechinger, C. 2002: Phase behavior of colloidal molecular crystals on triangular light lattices. Physical Review Letters 88(24): 248302

Harreis, H.M.; Kornyshev, A.A.; Likos, C.N.; Löwen, H.; Sutmann, G. 2002: Phase behavior of columnar DNA assemblies. Physical Review Letters 89(1): 018303

Di Biasio A; Cametti; Codastefano; Tartaglia; Rouch; Chen 1993: Phase behavior of dense three-component ionic microemulsions and electrical conductivity in the lamellar phase. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 47(6): 4258-4264

Veerman; Frenkel 1992: Phase behavior of disklike hard-core mesogens. Physical Review. A Atomic Molecular and Optical Physics 45(8): 5632-5648

Dijkstra, M. 2002: Phase behavior of hard spheres with a short-range Yukawa attraction. Physical Review. E Statistical Nonlinear and Soft Matter Physics 66(2 Part 1): 021402

Bates; Frenkel 2000: Phase behavior of model mixtures of colloidal disks and polymers. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 62(4 Part B): 5225-5229

Zhang; Laradji; Guo; Mouritsen; Zuckermann 1992: Phase behavior of pure lipid bilayers with mismatch interactions. Physical Review. A Atomic Molecular and Optical Physics 45(10): 7560-7567

Rosenbaum; Zamora; Zukoski 1996: Phase behavior of small attractive colloidal particles. Physical Review Letters 76(1): 150-153

Huang; Gibbs; Zehner; Sandy; Mochrie 1990: Phase behavior of the Au(111) surface: Discommensurations and kinks. Physical Review Letters 65(26): 3313-3316

Al-Bawab, A.; Friberg, S.E. 2002: Phase behavior of the alpha-hydroxyoctanoic acid/Laureth 4/white oil/water system and preliminary evaluation of the phase changes during evaporation of its emulsion. Journal of Cosmetic Science 53(3): 151-164

Bellini; Clark; Muzny; Wu; Garland; Schaefer; Oliver 1992: Phase behavior of the liquid crystal 8CB in a silica aerogel. Physical Review Letters 69(5): 788-791

Qiu, H.; Caffrey, M. 1999: Phase behavior of the monoerucin/water system. Chemistry and Physics of Lipids 100(1-2): 55-79

Wu, J.; Zhou, B.; Hu, Z. 2003: Phase behavior of thermally responsive microgel colloids. Physical Review Letters 90(4): 048304

Bechinger, C.; Brunner, M.; Leiderer, P. 2001: Phase behavior of two-dimensional colloidal systems in the presence of periodic light fields. Physical Review Letters 86(5): 930-933

Palakodaty, S.; York, P. 1999: Phase behavioral effects on particle formation processes using supercritical fluids. Pharmaceutical Research 16(7): 976-985

Ecke; Shu; Sullivan; Vilches 1985: Phase boundaries and critical and tricritical properties of monolayer 4He adsorbed on graphite. Physical Review. B Condensed Matter 31(1): 448-455

Chui 1994: Phase boundaries in ultrathin magnetic films. Physical Review. B Condensed Matter 50(17): 12559-12567

Fisher; Barbosa 1991: Phase boundaries near critical end points. I. Thermodynamics and universality. Physical Review. B Condensed Matter 43(13): 11177-11184

Barbosa; Fisher 1991: Phase boundaries near critical end points. II. General spherical models. Physical Review. B Condensed Matter 43(13): 10635-10646

Barbosa 1992: Phase boundaries near critical end points. III. Corrections to scaling and spherical models. Physical Review. B Condensed Matter 45(10): 5199-5208

Fujita; Okawa; Matsumoto; Tanaka 1996: Phase boundaries of nanometer scale c(2 x 2)-O domains on the Cu(100) surface. Physical Review. B Condensed Matter 54(3): 2167-2174

Montambaux; Naughton; Chamberlin; Yan; Chaikin; Azbel 1989: Phase boundary and magnetization in field-induced spin-density-wave systems. Physical Review. B Condensed Matter 39(1): 885-888

Hu; Huang 1991: Phase boundary of a cubic superconducting circuit in a magnetic field of arbitrary magnitude and direction. Physical Review. B Condensed Matter 43(10): 7718-7728

Yi; Hu 1992: Phase boundary of several multicube superconducting circuits in a magnetic field of arbitrary magnitude and direction. Physical Review. B Condensed Matter 46(9): 5448-5453

Chi; Santhanam; Blöchl 1990: Phase boundary of superconducting networks: a new approximation scheme. Physical Review. B Condensed Matter 42(1): 76-79

Rottman 1990: Phase boundary of the two-dimensional Ising model with ferromagnetic and antiferromagnetic interactions in a magnetic field. Physical Review. B Condensed Matter 41(4): 2547-2549

Marcus; Westervelt; Hopkins; Gossard 1993: Phase breaking in ballistic quantum dots: Experiment and analysis based on chaotic scattering. Physical Review. B Condensed Matter 48(4): 2460-2464

Bird; Ishibashi; Ferry; Ochiai; Aoyagi; Sugano 1995: Phase breaking in ballistic quantum dots: Transition from two- to zero-dimensional behavior. Physical Review. B Condensed Matter 51(24): 18037-18040

Moon, S.J.; Shattuck, M.D.; Bizon, C.; Goldman, D.I.; Swift, J.B.; Swinney, H.L. 2002: Phase bubbles and spatiotemporal chaos in granular patterns. Physical Review. e Statistical Nonlinear and Soft Matter Physics 65(1 Part 1): 011301

Aharonov; Anandan 1987: Phase change during a cyclic quantum evolution. Physical Review Letters 58(16): 1593-1596

Batten, S.R.; Harris, A.R.; Murray, K.S. 2000: Phase change in tetraphenylphosphonium perchlorate. Acta Crystallographica. Section C Crystal Structure Communications 56 Pt 11: 1394-1395

Wu, J.; Takeda, T.; Toyama, H.; Ajisaka, R.; Masuoka, T.; Watanabe, S.; Sato, M.; Ishikawa, N.; Itai, Y. 1999: Phase changes caused by hyperventilation stress in spastic angina pectoris analyzed by first-pass radionuclide ventriculography. Annals of Nuclear Medicine 13(1): 13-18

Liu, Z.; Lai, Y.C.; Hoppensteadt, F.C. 2001: Phase clustering and transition to phase synchronization in a large number of coupled nonlinear oscillators. Physical Review. E Statistical Nonlinear and Soft Matter Physics 63(5 Part 2): 055201

Hannon, J.B.; zu Heringdorf, F.J.; Tersoff, J.; Tromp, R.M. 2001: Phase coexistence during surface phase transitions. Physical Review Letters 86(21): 4871-4874

Knott, M.; Ford, I.J. 2001: Phase coexistence in colloidal suspensions: an analytic Poisson-Boltzmann treatment. Physical Review. E Statistical Nonlinear and Soft Matter Physics 63(3 Part 1): 031403

Moretto; Phair; Ghetti; Tso; Colonna; Skulski; Wozniak; Bowman; Carlin; Chartier; Gelbke; Gong; Hsi; Kim; Lisa; Lynch; Peaslee; Schwarz; de Souza RT; Tsang; Zhu 1996: Phase coexistence in multifragmentation?. Physical Review Letters 76(3): 372-375

Stevens; Grest 1995: Phase coexistence of a Stockmayer fluid in an applied field. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 51(6): 5976-5984

Rathe; Scully 1995: Phase coherence and decoherence in the correlated-spontaneous-emission laser. Physical Review. A Atomic Molecular and Optical Physics 52(4): 3193-3200

Kayanuma 1993: Phase coherence and nonadiabatic transition at a level crossing in a periodically driven two-level system. Physical Review. B Condensed Matter 47(15): 9940-9943

Mon; Teitel 1989: Phase coherence and nonequilibrium behavior in Josephson junction arrays. Physical Review Letters 62(6): 673-676

Brewer 1986: Phase coherence and quantized circulation transitions in superfluid helium. Physical Review Letters 57(7): 920

Liu; Giordano 1990: Phase coherence and the effect of an ac electric field on the conductance of a disordered one-dimensional system. Physical Review. B Condensed Matter 41(14): 9728-9735

Gould; Sachrajda; Feng; Delage; Kelly; Leung; Coleridge 1995: Phase coherence and trajectory trapping around one or two independently controllable antidots in quantum wires. Physical Review. B Condensed Matter 51(16): 11213-11216

Schmitteckert; Eckern 1996: Phase coherence in a random one-dimensional system of interacting fermions: a density-matrix renormalization-group study. Physical Review. B Condensed Matter 53(23): 15397-15400

Courtois; Gandit; Pannetier 1995: Phase coherence in a two-dimensional array of normal and superconducting wires. Physical Review. B Condensed Matter 51(14): 9360-9363

Liu; Wu; Tsong 1992: Phase coherence in atomic vibration in field dissociation of field desorbed diatomic ions. Physical Review. B Condensed Matter 45(7): 3659-3668

Miller; Gunaratne; Zou; Davis; Rampersad; Wolfe 1994: Phase coherence in the hysteretic magnetic behavior of parallel Josephson-junction arrays. Physical Review. B Condensed Matter 49(21): 15317-15321

Sásik; Stroud; Tesanovic 1995: Phase coherence in two-dimensional type-Ii superconductors. Physical Review. B Condensed Matter 51(5): 3042-3046

Zailer; Frost; Ford; Pepper; Simmons; Ritchie; Nicholls; Jones 1994: Phase coherence, interference, and conductance quantization in a confined two-dimensional hole gas. Physical Review. B Condensed Matter 49(7): 5101-5104

Baer, R.; Neuhauser, D. 2002: Phase coherent electronics: a molecular switch based on quantum interference. Journal of the American Chemical Society 124(16): 4200-4201

Schumacher, H.W.; Chappert, C.; Crozat, P.; Sousa, R.C.; Freitas, P.P.; Miltat, J.; Fassbender, J.; Hillebrands, B. 2003: Phase coherent precessional magnetization reversal in microscopic spin valve elements. Physical Review Letters 90(1): 017201

Reichert; Niering; Holzwarth; Weitz; Udem; Hansch 2000: Phase coherent vacuum-ultraviolet to radio frequency comparison with a mode-locked laser. Physical Review Letters 84(15): 3232-3235

Lera; Nieto-Vesperinas 1990: Phase conjugation by four-wave mixing of statistical beams. Physical Review. A Atomic Molecular and Optical Physics 41(11): 6400-6405

Saxena; Agarwal 1985: Phase conjugation by nondegenerate four-wave mixing with excited-state Zeeman coherences. Physical Review. A General Physics 31(2): 877-887

Sawley 1988: Phase conjugation in a moderately dense liquid suspension of microspheres. Physical Review. A General Physics 37(4): 1298-1302

Freysz; Laffon; Delville; Ducasse 1994: Phase conjugation in critical microemulsions. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 49(3): 2141-2149

Rogovin 1985: Phase conjugation in liquid suspensions of microellipsoids in the diffusive limit. Physical Review. A General Physics 32(5): 2837-2856

Rogovin; Sari 1985: Phase conjugation in liquid suspensions of microspheres in the diffusive limit. Physical Review. A General Physics 31(4): 2375-2389

Maki; Davis; Boyd; Sipe 1992: Phase conjugation using the surface nonlinearity of a dense potassium vapor. Physical Review. A Atomic Molecular and Optical Physics 46(11): 7155-7161

Belic 1988: Phase conjugation via multiple gratings in photorefractive crystals. Physical Review. A General Physics 37(5): 1809-1812

Su 1995: Phase considerations in the Thomas-WKB theory: Film structures, quantum wells, and quantum wires. Physical Review. B Condensed Matter 51(8): 5072-5077

You; Axe; Kan; Hashimoto; Moss; Liu; Crabtree; Lam 1988: Phase constitution and thermal expansion of YBa2Cu3O7- delta single crystals. Physical Review. B Condensed Matter 38(13): 9213-9216

Jones, R.; Pereira, J.; Santoreneos, S.; Vonau, M. 1998: Phase contrast MRi assessment of thoraco-lumbar spinal cord motion in spinal dysraphism. European Journal of Pediatric Surgery: Official Journal of Austrian Association of Pediatric Surgery . et Al 8(Suppl 1): 60-62

Markl, M.; Hennig, J. 2001: Phase contrast MRi with improved temporal resolution by view sharing: k-space related velocity mapping properties. Magnetic Resonance Imaging 19(5): 669-676

Naidich, T.P.; Altman, N.R.; Gonzalez-Arias, S.M. 1993: Phase contrast cine magnetic resonance imaging: normal cerebrospinal fluid oscillation and applications to hydrocephalus. Neurosurgery Clinics of North America 4(4): 677-705

Batra, S.; Sen, R.; Jain, K.; Gulati, N. 1995: Phase contrast microscopic evaluation of placental pathology in premature gestation. Indian Journal of Pathology and Microbiology 38(4): 407-411

Shahi, S.K.; Ranga, S.; Khurana, S.K.; Talib, V.H. 1999: Phase contrast microscopy: utility in obstetrics and gynaecology. Indian Journal of Pathology and Microbiology 42(2): 123-124

De Graef M; Nuhfer; McCartney 1999: Phase contrast of spherical magnetic particles. Journal of Microscopy 194(1): 84-94

Sheehy; Walker; DiMauro 1995: Phase control in the two-color photodissociation of HD+. Physical Review Letters 74(24): 4799-4802

Zuo; Bandrauk 1996: Phase control of molecular ionization: H2 + and H3 2+ in intense two-color laser fields. Physical Review. a Atomic Molecular and Optical Physics 54(4): 3254-3260

Gong, J.; Brumer, P. 2002: Phase control of nonadiabaticity-induced quantum chaos in an optical lattice. Physical Review Letters 88(20): 203001

Petrosyan; Lambropoulos 2000: Phase control of photoabsorption in optically dense media. Physical Review Letters 85(9): 1843-1846

Kaminski; Ehlotzky 1994: Phase control of scattering resonances in intense bichromatic laser fields. Physical Review. A Atomic Molecular and Optical Physics 50(5): 4404-4407

Gerkema, M.P.; Daan, S.; Wilbrink, M.; Hop, M.W.; van der Leest, F. 1993: Phase control of ultradian feeding rhythms in the common vole (Microtus arvalis): the roles of light and the circadian system. Journal of Biological Rhythms 8(2): 151-171

Petrashov; Antonov; Delsing; Claeson 1995: Phase controlled conductance of mesoscopic structures with superconducting "mirrors". Physical Review Letters 74(26): 5268-5271

Vining, B.A.; Bossio, R.E.; Marshall, A.G. 1999: Phase correction for collision model analysis and enhanced resolving power of fourier transform ion cyclotron resonance mass spectra. Analytical Chemistry 71(2): 460-467

Repp, B.H. 2001: Phase correction, phase resetting, and phase shifts after subliminal timing perturbations in sensorimotor synchronization. Journal of Experimental Psychology. Human Perception and Performance 27(3): 600-621

Schalow, G. 1993: Phase correlated adequate afferent action potentials as a drive of human spinal oscillators. Electromyography and Clinical Neurophysiology 33(8): 465-476

Björk; Yamamoto 1988: Phase correlation in nondegenerate parametric oscillators and amplifiers: Theory and applications. Physical Review. A General Physics 37(6): 1991-2006

Yevstafiev, V.V. 2001: Phase density method: a microscopic description of the gas of neutral particles. Physical Review. E Statistical Nonlinear and Soft Matter Physics 64(4 Pt 1): 041201

Protopapas; Knight; Burnett 1994: Phase dependence in two-color excitation of a model atom by intense fields. Physical Review. A Atomic Molecular and Optical Physics 49(3): 1945-1949

Véniard; Taïeb; Maquet 1996: Phase dependence of (N+1)-color (N>1) ir-uv photoionization of atoms with higher harmonics. Physical Review. a Atomic Molecular and Optical Physics 54(1): 721-728

Schumacher; Weihe; Muller; Bucksbaum 1994: Phase dependence of intense field ionization: a study using two colors. Physical Review Letters 73(10): 1344-1347

Schumacher; Bucksbaum 1996: Phase dependence of intense-field ionization. Physical Review. A Atomic Molecular and Optical Physics 54(5): 4271-4278

Takahashi; Kawamukai 2000: Phase detection of electrostatic force by AFM with a conductive tip. Ultramicroscopy 82(1-4): 63-68

Wang, C.M.; Chao, C.H.; Chang, S.L. 2001: Phase determination and extension using X-ray multiple diffraction and the maximum-entropy method. Acta Crystallographica. Section A Foundations of Crystallography 57(Part 4): 420-428

Koganezawa, T.; Yoshimura, Y.; Nakamura, N.; Iwasaki, H. 2001: Phase determination by wavelength-modulated diffraction. I. Centrosymmetric case. Journal of Synchrotron Radiation 8(3): 1035-1039

Clinton 1993: Phase determination in x-ray and neutron reflectivity using logarithmic dispersion relations. Physical Review. B Condensed Matter 48(1): 1-5

Schmidt; Colella 1985: Phase determination of forbidden x-ray reflections in V3Si by virtual Bragg scattering. Physical Review Letters 55(7): 715-717

Roach, J.; Retailleau, P.; Carter, C.W. 2001: Phase determination via Sayre-type equations with anomalous-scattering data. Acta Crystallographica. Section A Foundations of Crystallography 57(Part 3): 341-350

Voit 1992: Phase diagram and correlation functions of the half-filled extended Hubbard model in one dimension. Physical Review. B Condensed Matter 45(8): 4027-4042

Dünweg; Landau 1993: Phase diagram and critical behavior of the Si-Ge unmixing transition: a Monte Carlo study of a model with elastic degrees of freedom. Physical Review. B Condensed Matter 48(19): 14182-14197

Piercy; De'Bell; Pfnür 1992: Phase diagram and critical behavior of the adsorption system O/Ru(001): Comparison with lattice-gas models. Physical Review. B Condensed Matter 45(4): 1869-1877

Tavares; Telo da Gama MM; Teixeira; Weis; Nijmeijer 1995: Phase diagram and critical behavior of the ferromagnetic Heisenberg fluid from density-functional theory. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 52(2): 1915-1929

Jacobsen, J.L.; Picco, M. 2002: Phase diagram and critical exponents of a Potts gauge glass. Physical Review. e Statistical Nonlinear and Soft Matter Physics 65(2 Part 2): 026113

Bartelt; Einstein; Wille 1989: Phase diagram and critical properties of a two-dimensional lattice-gas model of oxygen ordering in YBa2Cu3Oz. Physical Review. B Condensed Matter 40(16): 10759-10765

Dorneich, A.; Hanke, W.; Arrigoni, E.; Troyer, M.; Zhang, S.C. 2002: Phase diagram and dynamics of the projected SO(5) symmetric model of high- T(c) superconductivity. Physical Review Letters 88(5): 057003

Patrick; Chen; Sher 1987: Phase diagram and local correlations in pseudobinary alloys. Physical Review. B Condensed Matter 36(12): 6585-6590

Ceder; Asta; Carter; Kraitchman; de Fontaine D; Mann; Sluiter 1990: Phase diagram and low-temperature behavior of oxygen ordering in YBa2Cu3Oz using ab initio interactions. Physical Review. B Condensed Matter 41(13): 8698-8701

Feng; Seehra 1992: Phase diagram and magnetic properties of the diluted fcc system NipMg1-pO. Physical Review. B Condensed Matter 45(5): 2184-2189

Zhang; Kim; Chan 1986: Phase diagram and phase transitions of monolayer and bilayer CF4 on graphite. Physical Review. B Condensed Matter 34(11): 8050-8063

Mehta, S.K.; Kawaljit 2002: Phase diagram and physical properties of a waterless sodium bis(2-ethylhexylsulfosuccinate)- ethylbenzene-ethyleneglycol microemulsion: an insight into percolation. Physical Review. E Statistical Nonlinear and Soft Matter Physics 65(2 Part 1): 021502

Gompper; Kroll 1995: Phase diagram and scaling behavior of fluid vesicles. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 51(1): 514-525

Althoff; Allen; Wentzcovitch; Moriarty 1993: Phase diagram and thermodynamic properties of solid magnesium in the quasiharmonic approximation. Physical Review. B Condensed Matter 48(18): 13253-13260

Hébert; Caillé; Bel Moufid A 1993: Phase diagram at T=0 of the one-dimensional chiral planar model in a twofold-anisotropy field. Physical Review. B Condensed Matter 48(5): 3074-3078

Kappler; Walker; Luettmer-Strathmann 1995: Phase diagram for UPd3 subject to symmetry-breaking stress and magnetic field. Physical Review. B Condensed Matter 51(17): 11319-11324

Straley; Barnett 1993: Phase diagram for a Josephson network in a magnetic field. Physical Review. B Condensed Matter 48(5): 3309-3315

Parker; Saslow; Gabay 1991: Phase diagram for a generalized fully frustrated triangular XY model. Physical Review. B Condensed Matter 43(13): 11285-11293

Zorzenon dos Santos RM; dos Santos RR 1988: Phase diagram for a random mixture of competing Ising anisotropies. Physical Review. B Condensed Matter 37(1): 569-572

Poniewierski; Sluckin 1991: Phase diagram for a system of hard spherocylinders. Physical Review. A Atomic Molecular and Optical Physics 43(12): 6837-6842

Poole; Essmann; Sciortino; Stanley 1993: Phase diagram for amorphous solid water. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 48(6): 4605-4610

Zanchi; Bjelis; Montambaux 1996: Phase diagram for charge-density waves in a magnetic field. Physical Review. B Condensed Matter 53(3): 1240-1250

Chen; Cross 1994: Phase diagram for coherent vortex formation in the two-dimensional inviscid fluid in circular geometries. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 50(3): 2022-2029

Leung; Chandler 1994: Phase diagram for excess electrons in simple fluids. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 49(4): 2851-2865

Schulte; Holzapfel 1993: Phase diagram for mercury up to 67 GPa and 500 K. Physical Review. B Condensed Matter 48(18): 14009-14012

Bauer; Dietrich 2000: Phase diagram for morphological transitions of wetting films on chemically structured substrates. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 61(2): 1664-1669

Maiti; Falicov 1992: Phase diagram for sodium clusters. Physical Review. A Atomic Molecular and Optical Physics 45(9): 6918-6921

Devereaux; Scalettar; Zimanyi; Moon; Loh 1995: Phase diagram for splay glass superconductivity. Physical Review Letters 75(26): 4768-4771

Kumar; Kurkijarvi; Oja 1985: Phase diagram for spontaneous nuclear magnetic ordering in copper. Physical Review. B Condensed Matter 31(5): 3194-3195

Cruz; Phillips 1994: Phase diagram for strongly correlated doped trans-polyacetylene chains. Physical Review. B Condensed Matter 49(8): 5149-5156

Straley 1994: Phase diagram for the Gaudin model. Physical Review. B Condensed Matter 49(9): 5806-5810

Ariaratnam, J.T.; Strogatz, S.H. 2001: Phase diagram for the Winfree model of coupled nonlinear oscillators. Physical Review Letters 86(19): 4278-4281

Kimel; Rikvold; Wang 1992: Phase diagram for the antiferromagnetic Blume-Capel model near tricriticality. Physical Review. B Condensed Matter 45(13): 7237-7243

Matthews; Strogatz 1990: Phase diagram for the collective behavior of limit-cycle oscillators. Physical Review Letters 65(14): 1701-1704

Shrimpton; Joós 1990: Phase diagram for the domain-wall lattice of krypton on graphite. Physical Review. B Condensed Matter 41(7): 4764-4767

Gabay; Garel; Parker; Saslow 1989: Phase diagram for the generalized Villain model. Physical Review. B Condensed Matter 40(1): 264-272

Yokota 1989: Phase diagram for the infinite-range transverse Ising spin-glass model. Physical Review. B Condensed Matter 40(13): 9321-9323

Arlett; Whitehead; MacIsaac; De'Bell 1996: Phase diagram for the striped phase in the two-dimensional dipolar Ising model. Physical Review. B Condensed Matter 54(5): 3394-3402

Zaluska-Kotur; Turski 1990: Phase diagram for the van der Waals-Potts fluid. Physical Review. A Atomic Molecular and Optical Physics 41(6): 3066-3069

Mukamel, E.A.; Shakhnovich, E.I. 2002: Phase diagram for unzipping DNA with long-range interactions. Physical Review. E Statistical Nonlinear and Soft Matter Physics 66(3 Part 1): 032901

Xu; Zhang 1994: Phase diagram in a two-dimensional Coulomb-gas model. Physical Review. B Condensed Matter 50(24): 18651-18653

Artuso; Borgonovi; Guarneri; Rebuzzini; Casati 1992: Phase diagram in the kicked Harper model. Physical Review Letters 69(23): 3302-3305

Shalaev, E.Y.; Steponkus, P.L. 1999: Phase diagram of 1,2-dioleoylphosphatidylethanolamine (DOPE):water system at subzero temperatures and at low water contents. Biochimica et Biophysica Acta 1419(2): 229-247

Tiwari; Glaberson 1990: Phase diagram of 3He-4He mixture films. Physical Review. B Condensed Matter 42(4): 2075-2083

Kim; Ma; Chan 1993: Phase diagram of 3He-4He mixture in aerogel. Physical Review Letters 71(14): 2268-2271

Zech; Lee; Keller; Blatter; Kes; Li 1996: Phase diagram of Bi2.15Sr1.85CaCu2O8+ delta in the presence of columnar defects. Physical Review. B Condensed Matter 54(9): 6129-6132

Knebel; Eggert; Engelmann; Viana; Krimmel; Dressel; Loidl 1996: Phase diagram of CeCu2(Si1-xGex)2. Physical Review. B Condensed Matter 53(17): 11586-11592

Lee; Ju; Kim 1994: Phase diagram of KH2(P1-xAsx)O4 mixed crystals. Physical Review. B Condensed Matter 49(14): 9958-9961

Gibaud; Shapiro; Nouet; You 1991: Phase diagram of KMn1-xCaxF3 (x<0.05) determined by high-resolution x-ray scattering. Physical Review. B Condensed Matter 44(6): 2437-2443

Lucarelli, A.; Lupi, S.; Ortolani, M.; Calvani, P.; Maselli, P.; Capizzi, M.; Giura, P.; Eisaki, H.; Kikugawa, N.; Fujita, T.; Fujita, M.; Yamada, K. 2003: Phase diagram of La2-xSrxCuO4 probed in the infared: imprints of charge stripe excitations. Physical Review Letters 90(3): 037002

Dahn 1991: Phase diagram of LixC6. Physical Review. B Condensed Matter 44(17): 9170-9177

Dahn; McKinnon 1985: Phase diagram of LixMo. Physical Review. B Condensed Matter 32(5): 3003-3005

Klee; Knorr 1991: Phase diagram of N2:Ar:CO solid solutions. Physical Review. B Condensed Matter 44(6): 2789-2791

Mukamel; Hastings; Corliss; Zhuang 1985: Phase diagram of NdSb: Type-i fcc antiferromagnet in a magnetic field. Physical Review. B Condensed Matter 32(11): 7367-7372

Berg; Beirl; Krishnan; Markum; Riedler 1996: Phase diagram of Regge quantum gravity coupled to SU(2) gauge theory. Physical Review. D Particles and Fields 54(12): 7421-7425

Kitazawa; Nomura; Okamoto 1996: Phase diagram of S=1 bond-alternating XXZ chains. Physical Review Letters 76(21): 4038-4041

Adenwalla; Lin; Ran; Zhao; Ketterson; Sauls; Taillefer; Hinks; Levy; Sarma 1990: Phase diagram of UPt3 from ultrasonic velocity measurements. Physical Review Letters 65(18): 2298-2301

Park; Joynt 1995: Phase diagram of UPt3 in the E1g model. Physical Review Letters 74(23): 4734-4737

Boubcheur; Loison; Diep 1996: Phase diagram of XY antiferromagnetic stacked triangular lattices. Physical Review. B Condensed Matter 54(6): 4165-4169

Kremer; Robbins; Grest 1986: Phase diagram of Yukawa systems: Model for charge-stabilized colloids. Physical Review Letters 57(21): 2694-2697

Lee, J.W.; Cha, M.C.; Kim, D. 2001: Phase diagram of a disordered boson Hubbard model in two dimensions. Physical Review Letters 87(24): 247006

Patel; Chen; Kumar 1993: Phase diagram of a frustrated smectic liquid-crystal system and the absence of the incommensurate smectic-Ai2 phase. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 47(4): 2643-2653

Cannas; Tsallis 1992: Phase diagram of a generalized t-J model: Renormalization-group approach. Physical Review. B Condensed Matter 46(10): 6261-6275

Honjo; Ohta; Matsushita 1987: Phase diagram of a growing succinonitrile crystal in supercooling-anisotropy phase space. Physical Review. A General Physics 36(9): 4555-4558

Dasgupta; Valls 2000: Phase diagram of a hard-sphere system in a quenched random potential: a numerical study. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 62(3 Part A): 3648-3658

Parlinski; Kwiecinski; Urbanski 1992: Phase diagram of a hexagonal model with incommensurate phases. Physical Review. B Condensed Matter 46(9): 5110-5115

Slotte 1992: Phase diagram of a lattice microemulsion model in two dimensions. Physical Review. A Atomic Molecular and Optical Physics 46(10): 6469-6478

Laradji; Guo; Grant; Zuckermann 1991: Phase diagram of a lattice model for ternary mixtures of water, oil, and surfactants. Physical Review. A Atomic Molecular and Optical Physics 44(12): 8184-8188

Lin; Shih; Bohanon; Ice; Dutta 1990: Phase diagram of a lipid monolayer on the surface of water. Physical Review Letters 65(2): 191-194

Müller, M. 2002: Phase diagram of a mixed polymer brush. Physical Review. E Statistical Nonlinear and Soft Matter Physics 65(3 Part 1): 030802

Sengupta; Marx; Nielaba; Binder 1994: Phase diagram of a model anticlustering binary mixture in two dimensions: a semi-grand-canonical Monte Carlo study. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 49(2): 1468-1477

Alvarez, G.; Mayr, M.; Dagotto, E. 2002: Phase diagram of a model for diluted magnetic semiconductors beyond mean-field approximations. Physical Review Letters 89(27): 277202

Santoro; Manini; Parola; Tosatti 1996: Phase diagram of a model of correlated hopping of electrons in a lattice of Berry molecules. Physical Review. B Condensed Matter 53(2): 828-836

Christiansen; He; Habip; Bauer; Krueger; Martienssen 1992: Phase diagram of a modulated relaxation oscillator with a finite resetting time. Physical Review. A Atomic Molecular and Optical Physics 45(12): 8450-8456

Meyer; Anglès d'Auriac JC 1995: Phase diagram of a six-state chiral Potts model. Physical Review. B Condensed Matter 51(10): 6379-6387

Schöll-Paschinger, E.; Levesque, D.; Weis, J.J.; Kahl, G. 2001: Phase diagram of a symmetric binary fluid in a porous matrix. Physical Review. E Statistical Nonlinear and Soft Matter Physics 64(1 Part 1): 011502

Veerman; Frenkel 1990: Phase diagram of a system of hard spherocylinders by computer simulation. Physical Review. A Atomic Molecular and Optical Physics 41(6): 3237-3244

Sebastianes; Figueiredo 1992: Phase diagram of a trimodal random surface field. Physical Review. B Condensed Matter 46(2): 969-972

Sebastianes; Figueiredo 1990: Phase diagram of a trimodal random-field spin-S Ising model. Physical Review. B Condensed Matter 42(4): 2594-2596

Liu; Einstein; Sterne; Wille 1995: Phase diagram of a two-dimensional lattice-gas model of oxygen ordering in YBa2Cu3Oz with realistic interactions. Physical Review. B Condensed Matter 52(13): 9784-9792

Chen, S.; Büttner, H.; Voit, J. 2001: Phase diagram of an asymmetric spin ladder. Physical Review Letters 87(8): 087205

Aligia; Arrachea; Gagliano 1995: Phase diagram of an extended Hubbard model with correlated hopping at half filling. Physical Review. B Condensed Matter 51(19): 13774-13777

Eggert, S.; Gustafsson, D.P.; Rommer, S. 2001: Phase diagram of an impurity in the spin-1/2 chain: two-channel Kondo effect versus Curie law. Physical Review Letters 86(3): 516-519

Grousson; Tarjus; Viot 2000: Phase diagram of an ising model with long-range frustrating interactions: a theoretical analysis. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 62(6 Part A): 7781-7792

Folkins; Walker; Chen 1991: Phase diagram of betaine calcium chloride dihydrate in an applied electric field. Physical Review. B Condensed Matter 44(1): 374-377

Henkel; Seno 1996: Phase diagram of branched polymer collapse. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 53(4): 3662-3672

Grumbach; Martin 1996: Phase diagram of carbon at high pressures and temperatures. Physical Review. B Condensed Matter 54(22): 15730-15741

Iota, V.; Yoo, C.S. 2001: Phase diagram of carbon dioxide: evidence for a new associated phase. Physical Review Letters 86(26 Part 1): 5922-5925

Lee; Lee; Kim 2000: Phase diagram of congested traffic flow: An empirical study. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 62(4 Part A): 4737-4741

Troyer; Kontani; Ueda 1996: Phase diagram of depleted Heisenberg model for CaV4O9. Physical Review Letters 76(20): 3822-3825

Brey; Guinea 2000: Phase diagram of diluted magnetic semiconductor quantum wells. Physical Review Letters 85(11): 2384-2387

Ma; Figueiredo 1996: Phase diagram of disordered boson systems in the presence of random hopping. Physical Review. B Condensed Matter 54(6): 4183-4188

Riseborough; Hanggi 1993: Phase diagram of doped oxide superconductors: a slave-boson approach. Physical Review. B Condensed Matter 47(17): 11540-11543

Kapusta 1990: Phase diagram of electroweak theory. Physical Review. D Particles and Fields 42(3): 919-925

Zielinska; Mukamel; Steinberg; Fishman 1986: Phase diagram of externally modulated Rayleigh-Bénard system near the codimension-two point. Physical Review. A General Physics 34(5): 4171-4180

Gompper; Kroll 1994: Phase diagram of fluid vesicles. Physical Review Letters 73(15): 2139-2142

Küpfer; Gordeev; Jahn; Kresse; Meier-Hirmer; Wolf; Zhukov; Salama; Lee 1994: Phase diagram of flux creep in melt-textured and single-crystalline YBa2Cu3O7- delta. Physical Review. B Condensed Matter 50(10): 7016-7025

Marenduzzo, D.; Trovato, A.; Maritan, A. 2001: Phase diagram of force-induced DNA unzipping in exactly solvable models. Physical Review. E Statistical Nonlinear and Soft Matter Physics 64(3 Part 1): 031901

Dijkstra, M.; van Roij, R.; Evans, R. 1999: Phase diagram of highly asymmetric binary hard-sphere mixtures. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 59(5 Part B): 5744-5771

Clement-Cottuz; Amokrane; Regnaut 2000: Phase diagram of highly asymmetric binary mixtures: a study of the role of attractive forces from the effective one-component approach. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 61(2): 1692-1702

Kumada, N.; Terasawa, D.; Shimoda, Y.; Azuhata, H.; Sawada, A.; Ezawa, Z.F.; Muraki, K.; Saku, T.; Hirayama, Y. 2002: Phase diagram of interacting composite fermions in the bilayer nu=2/3 quantum hall effect. Physical Review Letters 89(11): 116802

Almeida; Mills 1995: Phase diagram of magnetic multilayers: the role of biquadratic exchange. Physical Review. B Condensed Matter 52(18): 13504-13510

Fygenson; Braun; Libchaber 1994: Phase diagram of microtubules. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 50(2): 1579-1588

Bezryadin; Buzdin; Pannetier 1995: Phase diagram of multiply connected superconductors: a thin-wire loop and a thin film with a circular hole. Physical Review. B Condensed Matter 51(6): 3718-3724

Sfatos; Gutin; Shakhnovich 1993: Phase diagram of random copolymers. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 48(1): 465-475

Bak; Kleban; Unertl; Ochab; Akinci; Bartelt; Einstein 1985: Phase diagram of selenium adsorbed on the Ni(100) surface: a physical realization of the Ashkin-Teller model. Physical Review Letters 54(14): 1539-1542

Chavanis, P.H.; Ispolatov, I. 2002: Phase diagram of self-attracting systems. Physical Review. E Statistical Nonlinear and Soft Matter Physics 66(3 Pt 2a): 036109

Broughton; Li 1987: Phase diagram of silicon by molecular dynamics. Physical Review. B Condensed Matter 35(17): 9120-9127

Radovic; Ledvij; Dobrosavljevic-Grujic 1991: Phase diagram of superconducting-normal-metal superlattices. Physical Review. B Condensed Matter 43(10): 8613-8616

Bergerhoff; Freire; Litim; Lola; Wetterich 1996: Phase diagram of superconductors from nonperturbative flow equations. Physical Review. B Condensed Matter 53(9): 5734-5757

Antonevych, O.; Forstmann, F.; Diaz-Herrera, E. 2002: Phase diagram of symmetric binary fluid mixtures: first-order or second-order demixing. Physical Review. E Statistical Nonlinear and Soft Matter Physics 65(6 Part 1): 061504

Shevchenko 1994: Phase diagram of systems with pairing of spatially separated electrons and holes. Physical Review Letters 72(20): 3242-3245

Fang; Solovyev; Terakura 2000: Phase diagram of tetragonal manganites. Physical Review Letters 84(14): 3169-3172

Brussaard, P.; Fisher, S.N.; Guénault, A.M.; Hale, A.J.; Mulders, N.; Pickett, G.R. 2001: Phase diagram of the a and B phases of superfluid 3He in aerogel. Physical Review Letters 86(20): 4580-4583

Yamanaka; Hatsugai; Kohmoto 1994: Phase diagram of the Ashkin-Teller quantum spin chain. Physical Review. B Condensed Matter 50(1): 559-562

Chau, H.F.; Wan, K.Y. 1999: Phase diagram of the Biham-Middleton-Levine traffic model in three dimensions. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 60(5 Part A): 5301-5304

Rosengren; Lapinskas 1993: Phase diagram of the Blume-Emery-Griffiths model on the honeycomb lattice calculated by the cluster-variation method. Physical Review. B Condensed Matter 47(5): 2643-2647

Tétot; Kudrnovsk; Pasturel; Drchal; Weinberger 1995: Phase diagram of the Cu-Pd surface alloy: a first-principles calculation. Physical Review. B Condensed Matter 51(24): 17910-17915

Motta; Christensen 1991: Phase diagram of the Fe1-xCoxSi2 alloy in the fluorite form. Physical Review. B Condensed Matter 43(6): 4902-4907

Little; Zangwill 1992: Phase diagram of the Frenkel-Kontorova-Devonshire model. Physical Review. B Condensed Matter 46(13): 7981-7986

Coppersmith; Yu 1989: Phase diagram of the Hubbard model: a variational wave-function approach. Physical Review. B Condensed Matter 39(16): 11464-11474

Kaufman; Touma 1994: Phase diagram of the Ising model on percolation clusters. Physical Review. B Condensed Matter 49(14): 9583-9585

Berker; Hui 1993: Phase diagram of the Ising model on the square lattice with crossed diagonal bonds. Physical Review. B Condensed Matter 48(17): 12393-12398

Gocksch; Shen 1992: Phase diagram of the N=2 Kazakov-Migdal model. Physical Review Letters 69(19): 2747-2749

Yamanaka; Hatsugai; Kohmoto 1993: Phase diagram of the S=1/2 quantum spin chain with bond alternation. Physical Review. B Condensed Matter 48(13): 9555-9563

Novais, E.; Miranda, E.; Castro Neto, A.H.; Cabrera, G.G. 2002: Phase diagram of the anisotropic Kondo chain. Physical Review Letters 88(21): 217201

Shapira; Klein; Adler; Aharony; Harris 1994: Phase diagram of the dilute Ising spin glass in general spatial dimension. Physical Review. B Condensed Matter 49(13): 8830-8841

Berret; Bostoen; Hennion 1992: Phase diagram of the dipolar glass K1-x(NH4)xi. Physical Review. B Condensed Matter 46(21): 13747-13750

Dongen 1996: Phase diagram of the extended Hubbard model at weak coupling. Physical Review. B Condensed Matter 54(3): 1584-1596

Cannon; Fradkin 1990: Phase diagram of the extended Hubbard model in one spatial dimension. Physical Review. B Condensed Matter 41(13): 9435-9443

Kuroki; Kusakabe; Aoki 1994: Phase diagram of the extended attractive Hubbard model in one dimension. Physical Review. B Condensed Matter 50(1): 575-578

Gulácsi; Van Beijeren H; Levi 1993: Phase diagram of the five-vertex model. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 47(4): 2473-2483

Thijssen 1989: Phase diagram of the frustrated XY model on a triangular lattice. Physical Review. B Condensed Matter 40(7): 5211-5214

Gonnella; Maritan 1993: Phase diagram of the frustrated gauge-invariant Ising model. Physical Review. B Condensed Matter 48(2): 932-935

Dagotto; Moreo 1989: Phase diagram of the frustrated spin-1/2 Heisenberg antiferromagnet in 2 dimensions. Physical Review Letters 63(19): 2148-2151

Chubukov; Gagliano; Balseiro 1992: Phase diagram of the frustrated spin-1/2 Heisenberg antiferromagnet with cyclic-exchange interaction. Physical Review. B Condensed Matter 45(14): 7889-7898

Xu; Ting 1990: Phase diagram of the frustrated square Heisenberg lattice based upon a modified spin-wave theory. Physical Review. B Condensed Matter 42(10): 6861-6864

Scalettar; Scalapino; Sugar; Toussaint 1989: Phase diagram of the half-filled 3D Hubbard model. Physical Review. B Condensed Matter 39(7): 4711-4714

Blount; Varma; Aeppli 1990: Phase diagram of the heavy-fermion superconductor UPt3. Physical Review Letters 64(25): 3074-3077

Shenoy; Gupte 1988: Phase diagram of the lattice superconductor. Physical Review. B Condensed Matter 38(4): 2543-2554

Guerrero; Noack 1996: Phase diagram of the one-dimensional Anderson lattice. Physical Review. B Condensed Matter 53(7): 3707-3712

Tsunetsugu; Sigrist; Ueda 1993: Phase diagram of the one-dimensional Kondo-lattice model. Physical Review. B Condensed Matter 47(13): 8345-8348

Tsuchiizu, M.; Furusaki, A. 2002: Phase diagram of the one-dimensional extended Hubbard model at half filling. Physical Review Letters 88(5): 056402

Penc; Mila 1994: Phase diagram of the one-dimensional extended Hubbard model with attractive and/or repulsive interactions at quarter filling. Physical Review. B Condensed Matter 49(14): 9670-9678

Hirsch 1985: Phase diagram of the one-dimensional molecular-crystal model with Coulomb interactions: Half-filled-band sector. Physical Review. B Condensed Matter 31(9): 6022-6031

Ogata; Luchini; Sorella; Assaad 1991: Phase diagram of the one-dimensional t-J model. Physical Review Letters 66(18): 2388-2391

Usadel; Büttner; Kopec 1991: Phase diagram of the quantum Ising spin glass in a transverse field. Physical Review. B Condensed Matter 44(22): 12583-12585

De Souza AM 1993: Phase diagram of the quantum anisotropic Heisenberg model on a self-dual hierarchical lattice. Physical Review. B Condensed Matter 48(6): 3744-3746

Saguia, A.; Boechat, B.; Continentino, M.A. 2002: Phase diagram of the random Heisenberg antiferromagnetic spin-1 chain. Physical Review Letters 89(11): 117202

Fisch 1992: Phase diagram of the random chiral model. Physical Review. B Condensed Matter 46(18): 11310-11317

Nowotny, T.; Patzlaff, H.; Behn, U. 2002: Phase diagram of the random field Ising model on the Bethe lattice. Physical Review. E Statistical Nonlinear and Soft Matter Physics 65(1 Part 2): 016127

Sebastianes; Saxena 1987: Phase diagram of the random-field Ising model with a trimodal distribution. Physical Review. B Condensed Matter 35(4): 2058-2060

De Oliveira MJ 1991: Phase diagram of the spin-1/2 Heisenberg antiferromagnet on a square lattice with nearest- and next-nearest-neighbor couplings. Physical Review. B Condensed Matter 43(7): 6181-6183

Grollau, S. 2002: Phase diagram of the spin-3/2 Blume-Capel model in three dimensions. Physical Review. E Statistical Nonlinear and Soft Matter Physics 65(5 Part 2): 056130

Parlinski 1993: Phase diagram of the square-lattice model with 1q and 2q incommensurate modulations. Physical Review. B Condensed Matter 48(5): 3016-3021

Khachaturyan; Semenovskaya; Morris 1988: Phase diagram of the superconducting oxide YBa2Cu3O6+ delta. Physical Review. B Condensed Matter 37(4): 2243-2246

Barford; Lu 1991: Phase diagram of the t-J model: a semiclassical calculation. Physical Review. B Condensed Matter 43(4): 3540-3548

Houlrik; Jensen 1986: Phase diagram of the three-state chiral clock model studied by Monte Carlo renormalization-group calculations. Physical Review. B Condensed Matter 34(1): 325-329

Milman; Hauser; Figueiredo 1991: Phase diagram of the transverse Ising model in a random field. Physical Review. B Condensed Matter 43(16): 13641-13644

Mazzeo; Carlon; van Beijeren H 1995: Phase diagram of the two component body-centered solid-on-solid model. Physical Review Letters 74(8): 1391-1394

Nobre, F.D. 2001: Phase diagram of the two-dimensional +/-J Ising spin glass. Physical Review. E Statistical Nonlinear and Soft Matter Physics 64(4 Part 2): 046108

Yi; Zhang; Canright 1994: Phase diagram of the two-dimensional Anderson-Hubbard model. Physical Review. B Condensed Matter 49(22): 15920-15927

Dasgupta; Halley 1993: Phase diagram of the two-dimensional disordered Hubbard model in the Hartree-Fock approximation. Physical Review. B Condensed Matter 47(2): 1126-1129

Scalettar; Loh; Gubernatis; Moreo; White; Scalapino; Sugar; Dagotto 1989: Phase diagram of the two-dimensional negative-U Hubbard model. Physical Review Letters 62(12): 1407-1410

Poilblanc 1995: Phase diagram of the two-dimensional t-J model at low doping. Physical Review. B Condensed Matter 52(13): 9201-9204

Zhitomirsky; Ueda 1996: Phase diagram of the unconventional superconductor UPt3 in the weak-crystal-field model. Physical Review. B Condensed Matter 53(10): 6591-6604

Mirasso; Massidda 1989: Phase diagram of the "2+4" model in a mean-field approximation without correlations. Physical Review. B Condensed Matter 40(10): 7336-7339

Carriço; Camley; Stamps 1994: Phase diagram of thin antiferromagnetic films in strong magnetic fields. Physical Review. B Condensed Matter 50(18): 13453-13460

Abanov; Kalatsky; Pokrovsky; Saslow 1995: Phase diagram of ultrathin ferromagnetic films with perpendicular anisotropy. Physical Review. B Condensed Matter 51(2): 1023-1038

Janz; Lüpke; van Driel HM 1993: Phase diagram of vicinal Cu(111) surfaces as determined by second-harmonic generation. Physical Review. B Condensed Matter 47(12): 7494-7500

Pehlke; Tersoff 1991: Phase diagram of vicinal Si(001) surfaces. Physical Review Letters 67(10): 1290-1293

Tupitsyn; Wallin; Rosengren 1996: Phase diagram of vortices in double-layer quantum Hall systems. Physical Review. B Condensed Matter 53(12): R7614-R7617

Parts; Karimäki; Koivuniemi; Krusius; Ruutu; Thuneberg; Volovik 1995: Phase diagram of vortices in superfluid 3He-A. Physical Review Letters 75(18): 3320-3323

Martínez-Miranda; Kortan; Birgeneau 1987: Phase diagram, fluctuations, and phase transitions near the liquid-crystal nematic-smectic-A-smectic-C multicritical point. Physical Review. a General Physics 36(5): 2372-2383

Schulz 1986: Phase diagrams and correlation exponents for quantum spin chains of arbitrary spin quantum number. Physical Review. B Condensed Matter 34(9): 6372-6385

Landau; Binder 1985: Phase diagrams and critical behavior of Ising square lattices with nearest-, next-nearest-, and third-nearest-neighbor couplings. Physical Review. B Condensed Matter 31(9): 5946-5953

Fischer; Furrer; Kaldis; Kim; Kjems; Levy 1985: Phase diagrams and magnetic excitations in holmium phosphide. Physical Review. B Condensed Matter 31(1): 456-469

Roussel; Buisine; Maschke; Coqueret; Benmouna 2000: Phase diagrams and morphology of polymer dispersed liquid crystals based on nematic-liquid-crystal-monofunctional-acrylate mixtures. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 62(2 Part A): 2310-2316

Leatherman; Diehl 1996: Phase diagrams and rotated incommensurate phases of K, Rb, and Cs adsorbed on Ag(111). Physical Review. B Condensed Matter 53(8): 4939-4946

Sarmento; Kaneyoshi 1993: Phase diagrams and tricritical behavior of a diluted spin-1 transverse Ising model in a random field. Physical Review. B Condensed Matter 48(5): 3232-3239

Grushko; Gordon; Vagner; Wyder 1992: Phase diagrams at diamagnetic phase transitions. Physical Review. B Condensed Matter 45(6): 3119-3121

Carneiro; de Mello EV 1987: Phase diagrams for 3He-4He and H2-D2 mixtures adsorbed on graphite. Physical Review. B Condensed Matter 35(1): 358-369

Niskanen 1986: Phase diagrams for submonolayer films on weakly corrugated substrates. Physical Review. B Condensed Matter 33(3): 1830-1837

Bowling; Collings; Booth; Goodby 1993: Phase diagrams for the blue phases of highly chiral liquid crystals. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 48(5): 4113-4115

Balcerzak; Bobák 1993: Phase diagrams for the disordered Ising model with second-neighbor interactions. Physical Review. B Condensed Matter 47(2): 840-844

Harris; Aharony 1989: Phase diagrams for the randomly diluted resistor network and XY model. Physical Review. B Condensed Matter 40(10): 7230-7238

Giordano, F.; Rossi, A. 2000: Phase diagrams in the binary system. Bollettino Chimico Farmaceutico 139(4): 182-189

Lii; Wang 1995: Phase diagrams of a diluted Ising thin ferromagnetic film in a transverse field. Physical Review. B Condensed Matter 51(10): 6715-6718

Kaneyoshi; Li 1987: Phase diagrams of a disordered, ferromagnetic, binary Ising system. Physical Review. B Condensed Matter 35(4): 1869-1876

Hong; Fultz 1995: Phase diagrams of bcc alloys at low temperatures with ballistic atom movements. Physical Review. B Condensed Matter 52(9): 6230-6237

Caflisch; Blankschtein 1986: Phase diagrams of cubic systems under uniaxial quadratic symmetry-breaking fields. Physical Review. B Condensed Matter 34(1): 250-260

Khusid, B.; Acrivos, A. 1999: Phase diagrams of electric-field-induced aggregation in conducting colloidal suspensions. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 60(3): 3015-3035

Toledano; Figueiredo Neto AM; de Sant'Ana ZA 2000: Phase diagrams of lyotropic cholesteric fluids. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 61(1): 486-492

Lyra; da Silva CR 1992: Phase diagrams of magnetically disordered bilayers. Physical Review. B Condensed Matter 46(6): 3420-3426

Roussel, F.éd.ér.; Maschke, U.; Buisine, J.-M.; Coqueret, X.; Benmouna, M. 2002: Phase diagrams of monomer and uv-cured difunctional-acrylate-nematic-liquid-crystal systems. Physical Review. e Statistical Nonlinear and Soft Matter Physics 65(1 Part 1): 011706

Dinsmore; Yodh; Pine 1995: Phase diagrams of nearly-hard-sphere binary colloids. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 52(4): 4045-4057

Zubkus; Tornau; Lapinskas; Kundrotas 1991: Phase diagrams of oxygen ordering in high-temperature superconductors RBa2Cu3O7-x. Physical Review. B Condensed Matter 43(16): 13112-13117

Bauer; Riesenhuber; Geisel 1996: Phase diagrams of self-organizing maps. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 54(3): 2807-2810

Schaub; Mukamel 1985: Phase diagrams of systems exhibiting incommensurate structures. Physical Review. B Condensed Matter 32(10): 6385-6393

Strandberg, E.; Sparrman, T.; Lindblom, G. 2001: Phase diagrams of systems with cationic alpha-helical membrane-spanning model peptides and dioleoylphosphatidylcholine. Advances in Colloid and Interface Science 89-90: 239-261

Ni; Iwata 1995: Phase diagrams of the Blume-Emery-Griffiths model for semiconducting alloy systems (ABD2)1-x(CD)2x or. Physical Review. B Condensed Matter 52(5): 3214-3219

Nagai 1985: Phase diagrams of the corner cubic Heisenberg model and its site-diluted version on a triangular lattice: Renormalization-group treatment. Physical Review. B Condensed Matter 31(3): 1570-1578

Zamora; Pérez Alcázar GA; Bohórquez; Rosales Rivera A; Plascak 1995: Phase diagrams of the diluted and random-bond Ising model. Physical Review. B Condensed Matter 51(14): 9329-9332

Sano; Ono 1995: Phase diagrams of the electronic state of the one-dimensional d-p model. Physical Review. B Condensed Matter 51(2): 1175-1180

Goldschmidt; Xu 1985: Phase diagrams of the random-field Potts model in three dimensions. Physical Review. B Condensed Matter 32(3): 1876-1879

Wang; Lee; Kimel 1987: Phase diagrams of the spin-1 Ising Blume-Emery-Griffiths model: Monte Carlo simulations. Physical Review. B Condensed Matter 36(16): 8945-8947

Giamarchi; Lhuillier 1991: Phase diagrams of the two-dimensional Hubbard and t-J models by a variational Monte Carlo method. Physical Review. B Condensed Matter 43(16): 12943-12951

Tejero; Daanoun; Lekkerkerker; Baus 1994: Phase diagrams of "simple" fluids with extreme pair potentials. Physical Review Letters 73(5): 752-755

Hirvonen, T.P.; Aalto, H.; Pyykkö, I.; Juhola, M. 1997: Phase difference of vestibulo-ocular reflex in head autorotation test. Acta Oto-Laryngologica. Supplementum 529: 98-100

Wagner; Brecha; Schenzle; Walther 1992: Phase diffusion and continuous quantum measurements in the micromaser. Physical Review. A Atomic Molecular and Optical Physics 46(9): R5350-R5353

Grondalski, J.; Alsing, P.M.; Deutsch, I.H. 2001: Phase diffusion as a model for coherent suppression of tunneling in the presence of noise. Physical Review. E Statistical Nonlinear and Soft Matter Physics 63(1 Part 2): 016114

Blackburn; Gronbech-Jensen 1996: Phase diffusion in a chaotic pendulum. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 53(4): 3068-3072

D'Alessandro; Politi; Arecchi 1989: Phase diffusion in chaotic laser dynamics. Physical Review. A General Physics 40(9): 5464-5467

Wagner; Brecha; Schenzle; Walther 1993: Phase diffusion, entangled states, and quantum measurements in the micromaser. Physical Review. A Atomic Molecular and Optical Physics 47(6): 5068-5079

Schwarzer, R. 2002: Phase discrimination by automated BKD. Analytical and Bioanalytical Chemistry 374(4): 699-702

Schieve; McGowan 1993: Phase distribution and linewidth in the micromaser. Physical Review. A Atomic Molecular and Optical Physics 48(3): 2315-2323

Vogel; Schleich 1991: Phase distribution of a quantum state without using phase states. Physical Review. A Atomic Molecular and Optical Physics 44(11): 7642-7646

Hillery; Freyberger; Schleich 1995: Phase distributions and large-amplitude states. Physical Review. A Atomic Molecular and Optical Physics 51(3): 1792-1803

Brand 1985: Phase dynamics for incommensurate nonequilibrium systems. Physical Review. A General Physics 32(6): 3551-3553

Brand; Wesfreid 1989: Phase dynamics for pattern-forming equilibrium systems under an external constraint. Physical Review. A General Physics 39(12): 6319-6322

Brand 1985: Phase dynamics for spiraling Taylor vortices. Physical Review. A General Physics 31(5): 3454-3456

Brattkus; Misbah 1990: Phase dynamics in directional solidification. Physical Review Letters 64(16): 1935-1938

Fourtune; Rappel; Rabaud 1994: Phase dynamics near a parity-breaking instability. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 49(5): R3576-R3579

Meng; Chai; Zhang 1992: Phase dynamics of coherent light in the M-photon Jaynes-Cummings model. Physical Review. a Atomic Molecular and Optical Physics 45(3): 2131-2134

Hagberg; Meron; Passot 2000: Phase dynamics of nearly stationary patterns in activator-inhibitor systems. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 61(6 Part A): 6471-6476

Roth; Lücke; Kamps; Schmitz 1994: Phase dynamics of patterns: the effect of boundary-induced amplitude variations. Physical Review. e Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 50(4): 2756-2775

Wu; Andereck 1991: Phase dynamics of wavy vortex flow. Physical Review Letters 67(10): 1258-1261

Brand 1987: Phase dynamics with a material derivative due to a flow field. Physical Review. A General Physics 35(10): 4461-4463

Qu; Hu; Yang; Qin 1995: Phase effect in taming nonautonomous chaos by weak harmonic perturbations. Physical Review Letters 74(10): 1736-1739

Bauer; Kastner; Arnau; Salin; Fainstein; Ponce; Echenique 1992: Phase effect in the energy loss of H projectiles in Zn targets: Experimental evidence and theoretical explanation. Physical Review Letters 69(7): 1137-1139

Arnau; Bauer; Kastner; Salin; Ponce; Fainstein; Echenique 1994: Phase effect in the energy loss of hydrogen projectiles in zinc targets. Physical Review. B Condensed Matter 49(10): 6470-6480

Kasumova, R.J. 2002: Phase effects at fifth-harmonic generation. Applied Optics 41(21): 4385-4389

Silverans; Borghs; De Bisschop P; Van Hove M 1985: Phase effects in bichromatic field interactions with a two-level atom. Physical Review Letters 55(10): 1070-1073

Fowler, C.G.; Mikami, C.M. 1996: Phase effects on the middle and late auditory evoked potentials. Journal of the American Academy of Audiology 7(1): 23-30

Kibble; Vilenkin 1995: Phase equilibration in bubble collisions. Physical Review. D Particles and Fields 52(2): 679-688

Foffi, G.; McCullagh, G.D.; Lawlor, A.; Zaccarelli, E.; Dawson, K.A.; Sciortino, F.; Tartaglia, P.; Pini, D.; Stell, G. 2002: Phase equilibria and glass transition in colloidal systems with short-ranged attractive interactions: application to protein crystallization. Physical Review. E Statistical Nonlinear and Soft Matter Physics 65(3 Part 1): 031407

Umantsev; Olson 1993: Phase equilibria and transformations in adiabatic systems. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 48(6): 4229-4249

Sokolowska; Moscicki 2000: Phase equilibria in an athermal solution of platelike particles. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 62(4 Pt A): 5011-5026

Wnek; Moscicki 1996: Phase equilibria in solutions of disklike particles. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 53(2): 1666-1679

Wensink, H.H.; Vroege, G.J. 2002: Phase equilibria in systems of hard disks with thickness polydispersity. Physical Review. E Statistical Nonlinear and Soft Matter Physics 65(3 Part 1): 031716

Glotova, I.K.; Pavlovskaia, G.E.; Lashko, N.P.; Antonov, I.A.; Tolstoguzov, V.B. 1993: Phase equilibria in water-defatted milk proteins-carboxymethylcellulose sodium salt systems. Prikladnaia Biokhimiia i Mikrobiologiia 29(1): 161-169

Dubey; O'Shea 1994: Phase equilibria of Lennard-Jones dipolar plus quadrupolar fluids by Gibbs-ensemble Monte Carlo simulation. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 49(3): 2175-2183

Kyu; Chiu 1996: Phase equilibria of a polymer-smectic-liquid-crystal mixture. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 53(4): 3618-3622

Strange, J.H.; Allen, S.G.; Stephenson, P.C.; Matveeva, N.P. 1996: Phase equilibria of absorbed liquids and the structure of porous media. Magnetic Resonance Imaging 14(7-8): 963-965

Yan, Q.; de Pablo, J.J. 2002: Phase equilibria of charge-, size-, and shape-asymmetric model electrolytes. Physical Review Letters 88(9): 095504

Yan, Q.; de Pablo, J.J. 2001: Phase equilibria of size-asymmetric primitive model electrolytes. Physical Review Letters 86(10): 2054-2057

Page; Monson 1996: Phase equilibrium in a molecular model of a fluid confined in a disordered porous material. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 54(1): R29-R32

Ji, Y.; Heiblum, M.; Sprinzak, D.; Mahalu, D.; Shtrikman, H. 2000: Phase evolution in a Kondo-correlated system. Science 290(5492): 779-783

Carini; Feng; Li; Ruffini 1992: Phase evolution of the photon in Kerr spacetime. Physical Review. D Particles and Fields 46(12): 5407-5413

Jeong, J.H.; Goldenfeld, N.; Dantzig, J.A. 2001: Phase field model for three-dimensional dendritic growth with fluid flow. Physical Review. E Statistical Nonlinear and Soft Matter Physics 64(4 Part 1): 041602

Lue; Brenner 1993: Phase flow and statistical structure of Galton-board systems. Physical Review. E Statistical Physics Plasmas Fluids and Related Interdisciplinary Topics 47(5): 3128-3144

Meingast, C.; Pasler, V.; Nagel, P.; Rykov, A.; Tajima, S.; Olsson, P. 2001: Phase fluctuations and the pseudogap in YBa(2)Cu(3)O (x). Physical Review Letters 86(8): 1606-1609

Orr; Clem; Jaeger; Goldman 1986: Phase fluctuations in Josephson junctions. Physical Review. B Condensed Matter 34(5): 3491-3494

Rauf; Zubairy 1987: Phase fluctuations in a degenerate parametric amplifier. Physical Review. A General Physics 36(3): 1481-1483

Orszag; Saavedra 1991: Phase fluctuations in a laser with atomic memory effects. Physical Review. A Atomic Molecular and Optical Physics 43(1): 554-560

Andersen, J.O.; Al Khawaja, U.; Stoof, H.T.C. 2002: Phase fluctuations in atomic Bose gases. Physical Review Letters 88(7): 070407

Peng; Li 1992: Phase fluctuations in the Jaynes-Cummings model with and without the rotating-wave approximation. Physical Review. A Atomic Molecular and Optical Physics 45(5): 3289-3293

Van der Zant HS; Webster; Romijn; Mooij 1990: Phase fluctuations in two-dimensional superconducting weakly coupled wire networks. Physical Review. B Condensed Matter 42(4): 2647-2650

Wienold, J.; Jentoft, R.E.; Ressler, T. 2001: Phase formation during the decomposition of ammonium heptamolybdate--an in situ XAFS and XRD investigation. Journal of Synchrotron Radiation 8(Part 2): 677-679

Karpe; Larsen; Bottiger 1992: Phase formation induced by ion irradiation and electrical resistivity of aluminum-3d-transition-metal alloys. Physical Review. B Condensed Matter 46(5): 2686-2692

Denier van der Gon AW; Tromp 1992: Phase formation sequence and domain structure: a low-energy-electron-microscopy study of the Si(111)-( sqrt 3 x sqrt 3 )Ag surface. Physical Review Letters 69(24): 3519-3522

Schleich; Bandilla; Paul 1992: Phase from Q function via linear amplification. Physical Review. A Atomic Molecular and Optical Physics 45(9): 6652-6654

Mobley, C.D.; Sundman, L.K.; Boss, E. 2002: Phase function effects on oceanic light fields. Applied Optics 41(6): 1035-1050

Dalidovich, D.; Phillips, P. 2002: Phase glass is a Bose metal: a new conducting state in two dimensions. Physical Review Letters 89(2): 027001

Scholl, J.F.; Dereniak, E.L.; Descour, M.R.; Tebow, C.P.; Volin, C.E. 2003: Phase grating design for a dual-band snapshot imaging spectrometer. Applied Optics 42(1): 18-29

Brüssler; Metzner; Husemann; Lewerenz 1988: Phase identification in the Cu-In-S system by gamma - gamma perturbed angular correlations. Physical Review. B Condensed Matter 38(13): 9268-9271

Small, J.A.; Michael, J.R. 2001: Phase identification of individual crystalline particles by electron backscatter diffraction. Journal of Microscopy 201(Pt 1): 59-69

Love; Scott 2001: Phase identification of microfeatures using EPMA methods, especially high-resolution X-ray spectroscopy. Micron 32(2): 115-128

Sinha, S.; Oshiro, T.; Sinha, U.; Lufkin, R. 1997: Phase imaging on a .2-T MR scanner: application to temperature monitoring during ablation procedures. Journal of Magnetic Resonance Imaging: Jmri 7(5): 918-928

Lakshmi; Swain 1990: Phase in the correlated-emission laser. Physical Review. A Atomic Molecular and Optical Physics 42(9): 5632-5640

Dai, H.; Nguyen, Q.; Kidd, G.; Feth, L.L.; Green, D.M. 1996: Phase independence of pitch produced by narrow-band sounds. Journal of the Acoustical Society of America 100(4 Part 1): 2349-2351

Micheli-Tzanakou, E.; Pavlopoulos, S. 1997: Phase information in visual evoked potentials. Journal of Medical Systems 21(4): 219-227

Chen, Y.; Broschat, S.L.; Flynn, P.J. 1996: Phase insensitive homomorphic image processing for speckle reduction. Ultrasonic Imaging 18(2): 122-139